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PROJECT SUMMARY 
 
Title of research project: An evaluation of the impact of the Glasgow Diabetes Project 
on healthcare for people with type 2 diabetes. 
 
Research question:  In what way does the introduction of a new model of care for 
people with type 2 diabetes improve care management, patient’s health status, healthcare 
working practices, and patients’ satisfaction? 
 
Objectives: 
Primary objectives - 
1 To assess the extent to which the population of diabetic patients within an LHCC 
are identified and appropriately managed in terms of regular review 
2 To assess changes in clinical indices of diabetic care (retinal screening, foot care, 
glucose, HbA1c, CHD risk factors, CHD events, other co-morbidity) 
3 To evaluate accessibility and uptake of the service at the defined points of contact 
 
Secondary objectives- 
1 To assess general health status, health beliefs and health related behaviours across 
different diabetic client groups 
2 To examine patients perceptions of their care and their motivation to participate in 
their care 
3 Comparison with the ideal service and traditional care setting 
4 To enumerate contacts with health care professionals and other health-related 
activities such as exercise referral schemes 
5 To assess patients’ awareness of the impact of organisational change 
 
Design:  Quasi-experimental, using a range of quantitative and qualitative tools at 
baseline and at 12-18 months following implementation of the new service. 
 
Setting:  Greater Shawlands LHCC 
 
Subjects:  At the time of the study the population of people with diabetes in Greater 
Shawlands LHCC was approximately 1450 people.  Recruitment to the study of a 
representative sample was achieved by inviting every third person on each GP practice 
type 2 diabetes register to participate in the main study.  Recruitment for a focus group 
sub study was performed through purposeful sampling. 
 
Methods:  Patient questionnaires were used to evaluate subjective accounts of general 
health status and individuals' attitudes to their diabetes management before and after 
implementation of the new service (Appendix A). SPSS software was used for statistical 
analysis of responses. 
Clinical indicators of diabetes management were collected before and after by using the 
diabetes clinical information system, SCI-DC e.g. HbA1c, RBG, BP, HDL, total 
cholesterol, retinal screening, feet screening, smoking and exercise.  While the diabetes 
Lindsay G, McDowell J, McPhail K (2006) An evaluation of the impact of the Glasgow 
Diabetes project for healthcare for patients with type 2 diabetes. Nursing & Health Care, 
University of Glasgow, Glasgow ISBN: 9780852618233 
 
6 
clinical information system identified all electronically recorded information, this still 
necessitated a manual trawl of patients’ notes to collect incomplete data. 
 
Patients' perceptions of the change in service delivery were explored through 8 focus 
group interviews; 5 at baseline, and 3 at18 months thereafter. 
 
Primary healthcare professionals' perceptions of diabetes care were measured after the 
new service was established through a specially designed and validated questionnaire 
(Appendix B). 
 
Results:  Patient questionnaires showed some worsening in general health (due mainly to 
conditions other than diabetes, especially musculoskeletal conditions), and stasis in 
attitudes of individuals coping with diabetes over the time period. 
 
Clinical data showed statistically significant improvements in numerous indices of 
diabetes management including smoking, exercise, blood pressure and cholesterol levels. 
 
Analysis of qualitative data of patients' perceptions showed appreciation of the new 
service for its convenience and user friendliness.  Patients highlighted areas of service 
provision that are valued such as readiness of information and expertise and time to talk 
in depth with health care professionals. 
 
Professionals' perceptions questionnaire showed a high level of satisfaction with the new 
service. 
 
Conclusions:  The new model of care is as good as the old model in terms of clinical 
outcomes.  It has had a positive impact upon patients’ health status.  Furthermore it has 
been well received by patients and professionals and the study has also captured patients’ 
interests and suggestions regarding service improvement which have been fed back to 
service providers for the enhancement of future service development.  It is acknowledged 
that the service was still in a transition phase and that there was some overlap of service 
provision during this time. 
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PROJECT 
 
Introduction 
 
The organisation and management of diabetes care is a priority issue.  In Scotland about 
1:40 people have diabetes and this is expected to rise to 1:25 by 2010.  Nine percent of 
annual NHS expenditure is on diabetes, of which 4.7% is on Type 2 diabetes.  Guidelines 
for the development of diabetes services have directed recent innovations, most notably 
the NHS Health Services Guidelines' Key Features of a Good Diabetes Service, and the 
Scottish Diabetes Framework which lays out developmental stages for the coordination 
of all agencies involved in providing care for this client group.  The Glasgow Diabetes 
Project was designed to meet the requirements of these documents and provide a service 
that is more accessible and which will reduce morbidity and mortality associated with 
diabetes. 
 
The purpose of this research project has been to assess the extent to which the population 
of diabetic patients within an LHCC are identified and appropriately managed in terms of 
guidelines for best practice.  An assessment was undertaken across the Type 2 diabetic 
client group of general health status, clinical markers of diabetic care management, and 
patients' health beliefs and health related behaviours before and after implementation of 
the new model of diabetes care.  An outline of the key aspects of the patient journey 
including location of care; accessibility; uptake and systems for ongoing management 
was drawn.  This included patients' perceptions of their care and their participation in self 
care.  Healthcare professionals' perceptions of diabetes care were also measured across 
different professional groups using a specifically designed questionnaire. 
 
Methodology 
 
Research Governance 
 
Ethical approval for the study was granted by the Greater Glasgow Primary Care NHS 
Trust Research Ethics Committee (Community and Mental Health) at the end of June 
2003.  The same Trust also granted Research and Development Management Approval 
for the study at this time. 
 
Study Design 
 
The study is based on a quasi-experimental design using a range of quantitative and 
qualitative tools at baseline and 12-18 months following implementation of the new 
diabetes service.  The study comprised three distinct aspects to address the research 
question and objectives. Patients were invited to complete questionnaires as well as 
agreeing to the collection of various clinical parameters.  A subgroup was invited to take 
part in a Focus Group Study.  Thirdly, professionals involved in the care of diabetes were 
invited to complete a questionnaire to elicit their views and perceptions of diabetes care. 
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Participants 
 
Participants comprised adults, elderly and people from ethnic minorities with diabetes 
mellitus within Greater Shawlands LHCC.  At commencement of study 63028 patients 
were registered with practices within this LHCC, of which 1402 had type 2 diabetes. 
Healthcare professional participants were Practice Managers, Practice Nurses, District 
Nurses, Podiatrists, Dietitians and GP’s within Greater Shawlands LHCC. 
 
Data Collection 
 
To allow evaluation of the new diabetes model of care, data was collected using a range 
of quantitative and qualitative tools at baseline and at 12-18 months after implementation 
of the new service. 
 
Patients’ clinical data was obtained through liaison with staff at the Primary Care Trust 
Headquarters and following discussion with their Data Protection Officer.  Data which is 
centrally located in the new clinical information system was downloaded using patients’ 
CHI numbers for confidentiality.  This process proved both useful and also very time 
consuming - it provided access to data in line with data protection requirements but also 
delivered many repetitious and incomplete entries, requiring sifting, and identification of 
‘missing data’.  Missing data was obtained as far as possible through liaison with practice 
staff that have access to patients’ clinical records. 
 
Liaison with Practice Managers and staff at the Trust HQ information was obtained on 
practice sizes, numbers of patients with type 2 diabetes, and healthcare systems in place 
for diabetes management. Through liaison with Practice Managers, Practice Nurses and 
reception staff demographic information was obtained for all patients on practices’ type 2 
diabetes registers.  (For details of sampling strategy see below). 
 
Patient questionnaires were used to measure general health and well being (SF-36), 
subjective accounts of living with diabetes (PAID questionnaire) and social support 
networks (RAND Social Activities Questionnaire).  The SF-36 and PAID questionnaires 
were used at baseline and 12 months, but the Social Activities questionnaire was only 
used at baseline in response to patients comments regarding the usefulness and relevance 
of this questionnaire. 
 
Healthcare professionals’ perceptions of diabetes care were measured using the 
Perceptions Of Diabetes Questionnaire at one time point in July 2004.  The questionnaire 
was sent to all GP’s, Practice Nurses, District Nurses, Podiatrists, Dietitians and Practice 
Managers within Greater Shawlands LHCC – 112 people. 
 
Qualitative data was collected to explore patients’ perspectives of living with diabetes, 
their needs, and of healthcare provision, through use of focus group interviews (See 
Focus Group section of report for full details). 
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Sampling 
 
In order to recruit patients to the study every third patient on each practices Type 2 
diabetes register was selected.  Some stratified sampling was also undertaken in order to 
ensure representation of ethnic minority groups.  Five hundred and seventy six 
individuals were thus sent a letter with information about the study which also included a 
consent form for patients to sign and return if they were willing to participate i.e. to 
completing questionnaires and permit access to clinical records pertaining to their 
diabetes care.  Following a reminder letter to all individuals who had not responded 
within 4 weeks the number of patients who consented to participate was 140. Of these a 
small number passed away within the first few months of the study, leaving a sample 
group of 136 individuals for this section of the study.  (For information regarding 
sampling for the focus group study see the Focus Group section of the report). 
 
Results of Clinical data 
 
The results are presented in three stages.  Firstly patients’ clinical data is presented.  
Secondly professionals’ views of diabetes care are described. Thereafter, the findings of 
the Focus Group study are presented. 
 
The clinical data was analysed between before and after, time frames for comparison.  
They were further analysed by gender, age group and deprivation category.  Power 
calculations have been utilized where appropriate. 
 
Healthcare systems and processes of care 
 
Numbers of patients and prevalence of diabetes within Greater Shawlands LHCC can be 
seen at Table 1.1. 
 
Table 1.1: Greater Shawlands LHCC - summary figures 
 
 
Registered 
patients 
Registered patients with 
type 2 diabetes 
Prevalence of type 2 
diabetes 
Baseline* 63028 1402 2.2% 
Follow 
up** 
 
62635 
 
1522 
 
2.4% 
 
*As in summer 2003 
**  As in autumn 2004 
 
The majority of practices were providing level 3 care before the end of 2002, with one 
pilot practice providing this service from 2001.  At the time of commencing this study 
one practice was not providing level 3 care. Level 3 care is where the General 
Practitioner has a register of diabetic patients and offers care in line with agreed local 
Lindsay G, McDowell J, McPhail K (2006) An evaluation of the impact of the Glasgow 
Diabetes project for healthcare for patients with type 2 diabetes. Nursing & Health Care, 
University of Glasgow, Glasgow ISBN: 9780852618233 
 
10 
treatment guidelines. This includes regular call and review and action to improve control 
of diabetes.  In addition to regular monitoring and treatment of diabetes, the practice will 
undertake risk factor management as necessary.  The General Practice also provide an 
annual report (based on SIGN dataset) for each diabetic patient in their care.  Information 
from the practice is fed into the shared diabetes Clinical Information System. 
  
By the end of the study period all practices within this LHCC were providing level 3 care 
for patients.  Each practice has a named lead GP for diabetes care, who along with a 
Practice Nurse from each practice had undertaken the necessary accredited diabetic 
training course.  All community Dietitians and Podiatrists linked to the Diabetes project 
were also required to complete a credited diabetes course. 
 
All practices maintain a computerised register of diabetic patients, eighty five percent of 
which (n=12) are on the GPASS system and 15% of which (n=2) are not.  Similarly, 
annual recall for review of diabetic patients is implemented by all practices, the majority 
through the GPASS system, the remainder through other methods including box file and 
reference to previous clinic sheets.   
 
Patient demographics 
 
Patient demographics for the population, sample and LHCC are shown in Table 2.1. 
 
Table 2.1: Patient demographic details  
 
 Population Sample [LHCC exc sample] p-value 
Total Number 1402 136 1266 --- 
Gender 
   Female 
   Male 
 
662 (47%) 
740 (53%) 
 
55 (40%) 
81 (60%) 
 
607 (48%) 
659 (52%) 
0.10 
Mean Age (st dev) in years 63.76 (13.59) 65.38 (11.96) 63.57 (13.75) 0.08 
Age Category 
   <55 yrs 
   55-64 yrs 
   65-74 yrs 
   >74 yrs 
 
346 (25%) 
324 (23%) 
415 (30%) 
317 (23%) 
 
28 (21%) 
23 (17%) 
56 (41%) 
29 (21%) 
 
318 (25%) 
303 (24%) 
357 (28%) 
288 (23%) 
0.003 
Deprivation Category 
   1 
   2 
   3 
   4 
   5 
   6 
   7 
 
38 (3%) 
260 (19%) 
160 (11%) 
252 (18%) 
85 (6%) 
187 (13%) 
420 (30%) 
 
3 (2%) 
27 (20%) 
26 (19%) 
32 (24%) 
8 (6%) 
11 (8%) 
29 (21%) 
 
35 (3%) 
233 (18%) 
134 (11%) 
220 (17%) 
77 (6%) 
176 (14%) 
391 (31%) 
0.007 
Grouped Dep Cat 
   1 & 2 
   3, 4 & 5 
   6 & 7 
 
268 (21%) 
431 (34%) 
567 (45%) 
 
30 (22%) 
66 (49%) 
40 (29%) 
 
268 (21%) 
431 (34%) 
567 (45%) 
0.001 
Ethnic Origin 
   Asian 
   Other 
 
254 (18%) 
1148 (82%) 
 
8 (6%) 
128 (94%) 
 
246 (19%) 
1020 (81%) 
<0.001 
Mean RAND score (st dev) 
Missing N 
--- 28.43 (7.28) 
11 
--- --- 
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Proportions (and mean/standard deviation for age) given for LHCC type 2 Diabetic 
population and for Sample of 136. P-value is for chi-squared test of equal proportions 
comparing our sample against the remaining LHCC patients (as if we compared the full 
LHCC, the groups would not be independent). Significant differences shown in bold. 
There is evidence of a difference in the distributions of age category, deprivation 
category and ethnic origin between our sample and the rest of the LHCC. Unfortunately 
this means we cannot say our sample is representative of the full LHCC patient group at 
the time. 
 
Patient Questionnaires - General Health and Wellbeing (SF36) and Diabetes-specific 
(PAID) 
 
The SF-36 questionnaire is a widely used and well known tool which has been found to 
be reliable and valid in the measurement of general health and well being.  It consists of 
36 items and generates scores for eight domains of health: General Health, Physical 
Function, Social Function, Mental Health, Bodily Pain, Role Limitation – Physical, Role 
Limitation – Mental, and Energy / Vitality.  The scores range from 0-100, with 0 
indicative of poor health and well being and 100 indicative of excellent health and well 
being (Table 3.1). 
 
The PAID (problem areas in diabetes questionnaire) is a reliable and valid tool used to 
measure diabetes-specific emotional distress.  It was developed by the Joslin Diabetes 
Centre, Boston.  The PAID total score ranges from 0-100, with 0 being indicative of the 
least emotion distress relating to diabetes and 100 being indicative of the greatest 
emotion distress relating to diabetes (Table 3.1). 
 
Table 3.1: Overall patient questionnaire paired results  
  
 No Pairs Baseline† 1 yr follow up† Mean difference‡ p-value 95% CI for diff 
Physical Function  88 75 (50 - 89) 70 (33 - 85) -3.69 0.10 -8.05 to 0.67 
Role Limitation Physical 88 75 (0 - 100) 50 (0 - 100) -7.95 0.08 -16.88 to 0.97 
Role Limitation Mental 88 88 (33 - 100) 100 (0 – 100) -0.76 0.86 -9.37 to 7.85 
Social Function 88 89 (56 - 100) 78 (47 – 100) -4.68 0.07 -9.82 to 0.46 
Mental Health 88 71.59 (21.50) 69.73 (21.17) -1.86 0.18 -4.57 to 0.85 
Energy / Vitality 88 51.42 (24.27) 48.86 (22.82) -2.56 0.21 -6.55 to 1.43 
Bodily Pain 88 70.39 (27.27) 63.94 (29.39) -6.44 0.02 -11.71 to -1.18 
General Health 88 54.80 (24.17) 51.70 (23.00) -3.09 0.13 -7.15 to 0.96 
PAID 94 13 (5 – 25) 13 (6 - 27) 1.64 0.14 -0.57 to 3.84 
† Figures are mean (st dev) for mental health to general health and median (interquartile range) for physical function to 
social function and PAID [due to skewed distributions]. 
‡ Figures are mean for all [as distributions of differences are not skewed]. 
 
These results were further analysed to demonstrate changes in the different parameters 
and these are presented in Table 3.2. 
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Table 3.2: Overall questionnaire results that have increased, decreased or stayed the same 
 
 No Pairs Decreased Same Increased 
  N (%) Mean Diff N (%) N (%) Mean Diff 
Physical Function  88 43 (49%) -17.09 18 (21%) 27 (31%) 15.19 
Role Limitation Physical 88 29 (33%) -53.45 44 (50%) 15 (17%) 56.67 
Role Limitation Mental 88 21 (24%) -53.95 47 (53%) 20 (23%) 53.30 
Social Function 88 34 (39%) -27.44 33 (38%) 21 (24%) 24.81 
Mental Health 88 41 (47%) -11.61 22 (25%) 25 (28%) 12.48 
Energy / Vitality 88 46 (52%) -14.57 12 (14%) 30 (34%) 14.83 
Bodily Pain 88 37 (42%) -28.24 28 (32%) 23 (26%) 20.78 
General Health 88 51 (58%) -14.88 9 (10%) 28 (32%) 17.39 
PAID 94 36 (38%) -7.04 8 (9%) 50 (53%) 8.15 
 
Test used is students paired sample t-test. Taking the example of bodily pain (the only 
significant change here) we can say that there is evidence that the score decreased on 
average during the 1 year follow up period. It is highly likely that this change is between 
-11.71 and -1.18, with a best estimate of -6.44.  There is no evidence of any of the other 
domains changing, on average, over the period, however for the sample each one 
decreased with all the mean differences negative. 
 
These terms apply to all tests of this sort for patient questionnaire data and clinical data. 
For the full data set above results have also been broken down into the numbers that 
decreased, increased and stayed the same over the period although no frequency 
measures have been conducted. 
 
Following this the data set has been broken down into groups and this analysis repeated 
in order to find any changes within the different groups (Appendices 1; 2; 3; 4;.5; 6; 7;.8; 
9).  Analyses was conducted by gender, by age group and by deprivation category.  
 
From these, it can be seen that there were statistically significant deterioration in the 
mental health function for men but not for women (Appendix 1 and 2).  Those aged under 
55 years of age showed a significant deterioration in role limitation regarding physical, 
mental and general health aspects (Appendix 3).  This was not replicated across the other 
age bands of between 55 and 74 years.  The over 74 year old age group described a 
significant reduction in physical function and role, energy and bodily pain (Appendix 4, 
5, 6).  The 65 -74 year age group and 74 plus age group experienced deterioration in their 
PAID score (Appendices 5, 6). 
 
Only dep cats 1 and 2 showed a significant reduction in physical function and role and 
general bodily pain (appendix 7). 
 
Patient Clinical Data 
 
The clinical data in relation to the patients’ main diabetes and cardiac parameters are 
presented in Tables 4.1 and 4.2. 
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Table 4.1: Overall clinical paired results  
 
 No Pairs Baseline† 1 yr follow up† Mean difference p-value 95% CI for diff 
HbA1c 113 8.06 (1.92) 7.81 (1.51) -0.25 0.18 -0.62 to 0.12 
RBG 56 11.62 (3.93) 8.91 (3.11) -2.71 <0.001 -3.80 to -1.61 
Creatinine 109 94.15 (42.02) 97.25 (71.34) 3.10 0.43 -4.60 to 10.80 
Cholesterol 102 5.13 (1.07) 4.50 (0.93) -0.64 <0.001 -0.87 to -0.41 
HDL 71 1.20 (0.34) 1.43 (0.66) 0.22 0.001 0.09 to 0.36 
Systolic BP 130 145.22 (17.49) 140.15 (18.35) -5.08 0.01 -9.00 to -1.15 
Diastolic BP 130 79.96 (10.50) 75.13 (10.99) -4.83 <0.001 -6.88 to -2.78 
Weight 121 84.87 (17.06) 84.39 (17.01) -0.48 0.31 -1.43 to 0.46 
BMI 120 30.05 (5.49) 30.10 (5.37) 0.05 0.80 -0.35 to 0.45 
† Figures are mean (st dev). 
 
There was a significant improvement in random blood glucose, cholesterol levels, HDL 
and both systolic and diastolic blood pressures.  These were further analysed to compare 
increase, decrease or no change in result and are presented in Appendix 10. 
 
Table 4.2: Clinical results continued 
 
 Baseline 1 yr follow up p-value † 
Smoking Status 
   Current smoker 
   Ex smoker 
   Non smoker 
 
21 (18%) 
37 (32%) 
58 (50%) 
 
12 (10%) 
46 (40%) 
58 (50%) 
0.007 
Physical Activity 
   Physically impossible 
   Avoids even trivial 
   Light 
   Moderate 
   Heavy 
 
2 (4%) 
12 (25%) 
25 (52%) 
9 (19%) 
0 (0%) 
 
3 (6%) 
7 (15%) 
19 (40%) 
18 (38%) 
1 (2%) 
0.002 
Pulse Left 
   Present 
   Absent 
 
90 (99%) 
1 (1%) 
 
87 (96%) 
4 (4%) 
0.25 
Pulse Right 
   Present 
   Absent 
 
86 (99%) 
1 (1%) 
 
80 (92%) 
7 (8%) 
0.03 
Sense Left 
   Normal 
   Impaired 
 
78 (90%) 
9 (10%) 
 
80 (92%) 
7 (8%) 
0.73 
Sense Right 
   Normal 
   Impaired 
 
72 (89%) 
9 (11%) 
 
75 (93%) 
6 (7%) 
0.45 
Retina Left 
   Normal 
   Mild Background 
   Established 
 
50 (98%) 
0 (0%) 
1 (2%) 
 
49 (96%) 
1 (2%) 
1 (2%) 
0.68 
Retina Right 
   Normal 
   Mild Background 
   Established 
 
48 (98%) 
0 (0%) 
1 (2%) 
 
47 (96%) 
1 (2%) 
1 (2%) 
0.68 
† McNemars test used so only paired data is analysed. 
 
Taking Smoking status as an example, we can say that there is evidence that the 
distributions of proportions changed significantly over the 1 year follow up period. Here 
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the percentage of ex smokers increased significantly. Alternatively, there is no evidence 
of a change in the distribution of proportions of patients with their left pulse present, for 
example. These terms can be applied to all tests of this sort in the clinical data section. 
 
Following this the data set has been broken down into groups and analysis repeated in 
order to find any changes within the different groups according to gender, age and 
deprivation category (Appendices 11, 12, 13, 14, 15, 16, 17, 18, 19).  This further 
analysis presented a similar trend to the overall database. 
 
Where there are national standards set for clinical parameters, results were compared to 
these.  There was significant improvement in hyperlipidaemia and hypertension (Table 
4.3).  
 
 
 
Table 4.3: Clinical guidelines paired results 
 
 No pairs Baseline 1yr follow up p-value 
HbA1c 
   Poor control 
   Borderline Control 
   Good Control 
113  
41 (36%) 
42 (37%) 
30 (27%) 
 
39 (35%) 
39 (35%) 
35 (31%) 
0.83 
Creatinine 
   Normal 
   Elevated 
109  
102 (94%) 
7 (6%) 
 
97 (89%) 
12 (11%) 
0.06 
Hyperlipidaemia 
   Normal 
   Elevated 
102  
50 (49%) 
52 (51%) 
 
77 (76%) 
26 (25%) 
<0.001 
HDL 
   Normal 
   Low 
71  
58 (82%) 
13 (18%) 
 
62 (87%) 
9 (13%) 
0.29 
Hypertension 
   Normal 
   Elevated 
130  
45 (35%) 
85 (65%) 
 
71 (55%) 
59 (45%) 
0.001 
BMI 
   Normal 
   Overweight 
120  
19 (16%) 
101 (84%) 
 
21 (18%) 
99 (82%) 
0.77 
McNemars test used so only paired data analysed. 
 
Results were compared between the clinical parameters measured and patients’ self 
reporting of areas from the SF36, the RAND and the PAID questionnaires.  These are 
presented in Table 4.4 and 4.5. 
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Table 4.4: Patient questionnaire / Clinical data relationships 
 
1 yr follow up HbA1c RBG Creatinine Chol. HDL Systolic Diastolic Weight BMI RAND 
Physical Function‡ 
p-value 
0.018 
0.82 
-0.097 
0.35 
0.152 
0.07 
0.080 
0.33 
-0.016 
0.87 
-0.078 
0.303 
0.049 
0.52 
-0.111 
0.15 
-0.252 
0.001 
0.120 
0.115 
Role Limitation Physical‡ 
p-value 
0.067 
0.45 
0.042 
0.72 
0.214 
0.02 
0.024 
0.79 
-0.137 
0.20 
-0.033 
0.69 
0.105 
0.21 
0.012 
0.89 
-0.127 
0.14 
0.034 
0.68 
Role Limitation Mental‡ 
p-value 
0.005 
0.96 
-0.102 
0.38 
0.309 
0.001 
0.010 
0.91 
-0.102 
0.36 
0.072 
0.40 
0.038 
0.66 
0.034 
0.70 
-0.114 
0.20 
0.078 
0.37 
Social Function‡ 
p-value 
0.097 
0.24 
-0.028 
0.79 
0.130 
0.13 
-0.019 
0.82 
-0.054 
0.60 
0.008 
0.92 
-0.012 
0.88 
-0.136 
0.09 
-0.237 
0.004 
0.189 
0.02 
Mental Health† 
p-value 
0.007 
0.95 
-0.222 
0.13 
0.284 
0.015 
-0.020 
0.87 
-0.031 
0.82 
0.063 
0.44 
0.021 
0.84 
-0.105 
0.35 
-0.274 
0.01 
0.303 
0.004 
Energy/ Vitality† 
p-value 
0.006 
0.96 
-0.175 
0.24 
0.175 
0.14 
0.014 
0.91 
-0.036 
0.79 
0.058 
0.59 
0.057 
0.60 
-0.187 
0.09 
-0.290 
0.006 
0.215 
0.046 
Bodily Pain† 
p-value 
-0.023 
0.84 
-0.152 
0.31 
0.101 
0.40 
0.093 
0.43 
-0.079 
0.56 
0.007 
0.95 
0.009 
0.93 
-0.186 
0.092 
-0.344 
0.001 
0.100 
0.36 
General Health† 
p-value 
-0.86 
0.46 
-0.294 
0.045 
0.177 
0.14 
-0.041 
0.73 
0.136 
0.32 
-0.019 
0.86 
-0.100 
0.35 
-0.190 
0.09 
-0.237 
0.03 
0.213 
0.048 
PAID‡ 
p-value 
0.080 
0.30 
0.174 
0.08 
-0.276 
<0.001 
0.068 
0.39 
0.007 
0.94 
-0.069 
0.34 
-0.053 
0.47 
0.151 
0.04 
0.178 
0.019 
-0.136 
0.06 
† Figures are r values (Pearson). 
‡ Figures are z values (Kendall). 
 
 
 
Table 4.5: Patient questionnaire / Clinical data relationships cont. 
 
1 yr follow up Current Smoker Ex Smoker Non Smoker p-value 
Physical Function‡ 70 (65 – 85) 60 (45 – 85) 75 (30 – 90) 0.76 
Role Limitation Physical‡ 75 (25 – 100) 75 (0 – 100) 25 (0 – 100) 0.35 
Role Limitation Mental‡ 33 (0 – 100) 100 (33 – 100) 100 (0 – 100) 0.27 
Social Function‡ 100 (22 – 100) 78 (33 – 100) 78 (56 – 100) 0.98 
Mental Health† 69.00 (21.31) 70.29 (20.75) 68.57 (23.13) 0.95 
Energy/ Vitality† 50.42 (29.73) 46.25 (20.35) 50.48 (23.24) 0.74 
Bodily Pain† 74.17 (27.82) 62.75 (26.18) 60.62 (30.77) 0.36 
General Health† 49.92 (26.03) 55.36 (23.35) 51.98 (22.27) 0.75 
PAID‡ 13 (6 – 51) 10 (8 – 20) 16 (5 – 28) 0.87 
† Figures are mean (st dev), test is students’ two independent samples t-test. 
‡ Figures are median (interquartile range), test is kruskal wallis test. 
 
 
Table 4.6: Patient questionnaire / Clinical predictors 
 
Outcome (at 
follow up) 
Adjusted R2 Sample size Predictors (at baseline) P-value Coefficient estimate & 95% CI 
Mental Health 67% 88 SF36 Mental Health <0.001 0.81 (0.69 to 0.93) 
Energy/ Vitality 46% 88 SF36 Energy/ Vitality <0.001 0.64 (0.49 to 0.79) 
Bodily Pain 38% 88 SF36 Bodily Pain <0.001 0.67 (0.48 to 0.85) 
General Health 45% 88 SF36 General Health <0.001 0.64 (0.49 to 0.79) 
HbA1c 11% 113 HbA1c <0.001 0.27 (0.13 to 0.41) 
Systolic BP 34% 130 Systolic BP 0.02 0.22 (0.04 to 0.40) 
Diastolic 15% 130 Diastolic BP <0.001 0.41 (0.25 to 0.58) 
BMI 84% 120 BMI <0.001 0.89 (0.83 to 0.97) 
 
Backward stepwise selection (involving first order terms for baseline value of response 
variable and baseline values for HbA1c, BP’s, BMI, age, sex, dep cat, RAND, ethnic 
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origin, practice and smoking status) was carried out to come up with the final models 
displayed in Tables 4.4; 4.5; 4.6. In all cases only the baseline value of the variable in 
question was found to be significant in contributing to follow up value. Therefore there is 
no evidence that the aforementioned variables (in the list in brackets) predict the outcome 
value in each case.  This cannot be done for remaining SF36 scores and PAID as they are 
not distributed normally and so cannot be entered into a linear regression model. 
 
The management of diabetes can be monitored through assessment of clinical measures 
of optimal care as outlined within the new GMS contract of 2003 (Investing in General 
Practice 2003 www.bma.org.uk ).  Key clinical indices for diabetes management were 
analysed for patients achieving or exceeding targets as can be seen from Table 4.7.  
Targets used were those defined in SIGN guidelines.  There was an improvement in the 
majority of measures after the introduction of the new service. 
 
Table 4.7: Key clinical variables baseline and one year following implementation of the 
new Community-based diabetic service 
 Baseline 
% (n) 
One year after 
introduction of 
new service 
% (n) 
Change from baseline 
P-value 
p 
 Systolic BP <130mmHg 14.6% 
(n=130) 
26.5% 
(n=136) 
0.0362* 
Diastolic BP <85mmHg 69.2% 
(n=130) 
85.3% 
(n=136) 
0.0020* 
Total cholesterol < 5 
mmol/L 
47.1% 
(n=104)) 
68.5% 
(n=130) 
0.0005* 
BMI <25kg/m2 11.3% 
(n=134) 
9.2% 
(n=130) 
0.3743 
BMI <30kg/m2 54.0% 
(n=134) 
56.2% 
(n=130) 
0.8203 
HBA1c <7.5 
 
45.7% 
(n=116) 
49.2%  
(n=132) 
0.4736 
 
Random blood sugar <8 17.9% 
(n=67) 
45.2% 
(n=73) 
0.0043* 
 
* Statistically significant at p< 0.05 level 
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Medication prescriptions 
 
Data was captured on prescribing practices at two time points.  The first was at the 
beginning of the service redesign and the second was at 2 years after initiation of the 
change in service.  Data was collected on the 138 patients who had consented. 
 
Table 5.1: Changes in prescription of sulphonylureas 
 
Follow up Sulphonylureas 
Not on drug On drug Total 
Not on drug 72(56%) 18 (14%) 90 
On drug 9 (7%) 29(23%) 38 (30%) 
Baseline 
Total 81 47 (37%) 128 
Missing N: 8 (6%);  P value 0.12 
 
The percentage of patients in the sample on a sulphonylurea increased from 30% to 37% 
at follow up.  This was not found to be statistically significant (using a 0.05 significance 
level) so there is not enough evidence to say that this increase was not a random 
occurrence. 
 
There were 26 patients on gliclazide at both time points.  The median dose at baseline 
was 100mg and this was found to increase to 160mg at follow up.  The Wilcoxon Signed 
rank test produced a p-value of 0.009.  On average, there was a significant increase in the 
prescribing dose of Gliclazide to patients that were on the drug at both baseline and 
follow up.   
 
There were insufficient numbers of patients on other sulphonylureas for statistical 
analysis. Categorical change in dose for all sulphonlyurea drugs was undertaken. From 
this, 66% of patients remained on the same dose, 35% experienced an increase in dose 
and no-one had their dose decreased. 
 
Table 5.2: Change in prescription of metformin 
 
Follow up Metformin 
Not on drug On drug Total 
Not on drug 62(49%) 22(17) 84 
On drug 3 (2%) 40(32%) 43 (34%) 
Baseline 
Total 65 62 (49%) 127 
Missing N: 9 (7%);  P-value <0.001 
 
There was a statistically significant increase in the prescribing of Metformin.  This was 
true for the increase in dose and the frequency of prescription. 
 
While there was an increase in the number of patients who required insulin from baseline 
to follow up, this was not statistically significant. 
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Table 5.3: Change in prescription of all diabetes medications 
 
Follow up Sulphonylureas,  Metformin, 
Insulin, Triglitazones Not on drug On drug Total 
Not on drug 34 (27%) 18 (14%) 52 
On drug 0 (0%) 76 (59%) 76 (59%) 
Baseline 
Total 34 94 (73%) 128 
Missing N: 8 (6%);  P-value<0.001 
 
The percentage of patients on any diabetic drugs increased from 59% to 73% between 
baseline and follow up.  This change occurred through 14% of patients commencing a 
drug during this period, while no-one who was on a drug at baseline was taken off it. 
There was a significant increase in the proportion of patients that were prescribed some 
form of diabetes medication and could suggest that this was due to improved 
management from the new service. 
 
 
Table 5.4: Change in number of diabetes medications 
 
No. pairs Decreased No 
drugs 
Same No. 
drugs 
Increased No. 
drugs 
P-value 
126 5 (4%) 82(65%) 39 (31%) 0.001 
There was a statistically significant difference between baseline and follow up that the 
number of diabetes drugs prescribed to patients increased (Table 5.4). 
 
 
 
Table 5.5: Change in prescription of Ace Inhibitors 
Follow up Ace Inhibitors 
Not on drug On drug Total 
Not on drug 69 (54%) 20 (16%) 89 
On drug 2 (2%) 37 (29%) 39 (31%) 
Baseline 
Total 71 57 (45%) 128 
Missing N: 8 (6%);  P-value<0.001 
 
 
Table 5.6: Change in prescription of Angiotensin Receptor Antagonists (ARA) 
 
Follow up ARA 
Not on drug On drug Total 
Not on drug 114 (90%) 6 (5%) 120 
On drug 0 (0%) 7 (6%) 7 (6%) 
Baseline 
Total 114 (90%) 13 (10%) 127 
Missing N: 9 (7%);  P-value<0.031 
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Table 5.7: Change in prescription of all hypertensive drugs 
 
Follow up All hypertensive drugs 
Not on drug On drug Total 
Not on drug 34 (27%) 18 (14%) 52 
On drug 0 (0%) 76 (59%) 76 (59%) 
Baseline 
Total 34 94 (73%) 128 
Missing N: 8 (6%);  P-value<0.001 
 
 
Table 5.8: Change over time in prescription of statins 
 
Follow up All hypertensive drugs 
Not on drug On drug Total 
Not on drug 36 (28%) 32 (25%) 68 
On drug 1 (1%) 59 (46%) 60 (47%) 
Baseline 
Total 37 91 (71%) 128 
Missing N: 8 (6%);  P-value<0.001 
 
Table 5.9: Change in prescription of adspirin 
 
Follow up Aspirin 
Not on drug On drug Total 
Not on drug 60 (47%) 24 (19%) 84 
On drug 2 (2%) 41 (32%) 43 (34%) 
Baseline 
Total 62 65(51%) 127 
Missing N: 8 (6%); P-value<0.001 
 
There was statistical significance in the prescribing of all Ace inhibitors, ARAs, 
hypertensive drugs, statins and aspirin (Table 5.5; 5.6; 5.7; 5.8; 5.9)    
 
There were no statistically significant results around the prescribing of the triglitazones; 
diuretics, beta blockers. 
 
Data were analysed to determine if there was a link between the changes in diabetes drug 
usage to changes in diabetes clinical measurements. Those patients who had experienced 
an improvement in their HbA1c between baseline and follow up were examined for 
prescription aspects.  There were 61 people in total. There was no significant difference 
in prescriptions of any drug in relation to improvement of diabetes clinical parameters.  
Those patients who showed an improvement in clinical measurements also had their dose 
increased on average and suggests that this led to the improvement. 
 
Data were analysed to determine if there was a link between the changes in hypertension 
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drug usage to changes in hypertension clinical measurements.  Changes in prescription of 
all hypertensive drugs had a statistically significant result for both systolic and diastolic 
blood pressure. 
 
Data were analysed to determine if there was a link between the changes in cholesterol 
drug use to changes in cholesterol clinical measurements.  The change in prescription of 
statins was statistically significant (p<0.001). 
 
Of 127 patients records reviewed, only 5 were referred to an exercise programme as part 
of their diabetes management.  
 
There was a median of 15.5 visits per patient for GP attendances for non diabetes reasons 
in the 2 year period (range 10-26.75); median 2 visits per patient for GP diabetes 
attendances; only one GP emergency diabetes attendance. 
 
Data was collected to determine hospital admissions and clinic attendances (Table 5.10; 
5.11).  GP attendances were separated between routine GP care and attendances 
specifically for diabetes care.  Hospital attendances were separated between clinic 
appointments for diabetes and for other clinical situations e.g. cancer. 
 
Table 5.10: GP attendances 
 Missing Data Frequency of 
Zero 
Median IQ Range * 
GP 
attendances 
8 (6%) 0 (0%) 15.5 10-26.75 
GP diabetes 
attendances 
10 (7%) 9 (7%) 2 1-4 
Emergency GP 
Diabetes  
10 (7%) 122 (97%) 1 1-1 
GP DNAs 9 (6%) 106 (84%) 1 1-1 
* for patients with more than one attendance/DNA 
 
Table 5.11: Hospital attendances 
 Missing Data Frequency of 
Zero 
Median IQ Range * 
Hospital 
appointments 
19 (14%) 82 (70%) 1 1-2 
Hospital 
diabetes clinics 
19 (14%) 20 (17%) 3 2-6 
Hospital clinic 
DNAs  
17 (13%) 33 (28%) 2 1-2 
* for patients with more than one appointment/diabetes clinic DNA 
 
During the data collecting period, there was one person who had a myocardial infarction; 
four who had an anginal attack and four who had a cerebrovascular accident. 
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Professionals’ Perceptions of Diabetes 
 
There were 112 numbers of professionals within the population.  All were sent the PODQ 
and asked to complete and return it. The response rate was 34% (n=38) and their 
demographic details are below. 
 
Gender:  Males: 9 (24%) 
   Females: 29 (76%) 
 
Qualification year:  Before 1991: 28 (78%) 
   1991 – 1995: 4 (11%) 
   1996 – 2000: 4 (11%) 
   Unknown: 2 
 
Profession:  Practice Manager: 2 (5%) General Practitioner: 14 (37%) 
   Practice Nurse: 12 (32%) Podiatrist: 5 (13%) 
   Dietitian: 1 (3%)  District Nurse: 4 (11%) 
 
Diabetic Training: Bradford: 15 (39%), Warwick: 4 (11%), Other: 5 (13%) 
 
Practice Organisation 
 
When asked who runs the diabetic clinic in your practice the responses were: 
GP only: 4 (11%);  
PN only: 5 (13%) 
GP and PN: 20 (53%) 
GP, PN, Podiatrist and Dietitian: 8 (23%) 
 
When asked how much time was spent with each client the responses were: 
10 mins: 2 (6%) 
15 mins: 1 (3%) 
20 mins: 7 (21%) 
30mins: 24 (71%) 
 
All were asked about their satisfaction with care delivery, their workloads and how these 
were linked to resources (Tables 6.1 - 6.4). 
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Table 6.1: Satisfaction with the care delivery system. 
1 (not at all 
satisfied) 
2 3 4 5 (very 
satisfied) 
p-value 
0 (0%) 2 (5%) 3 (8%) 17 (45%) 16 (42%) <0.001 
Chi-squared test for equal proportions used. There is evidence that the proportions are not 
equal and it appears that in general HCP’s are satisfied with the new system of care. 
 
Table 6.2: Workload attributed to diabetic care. 
1 (too much) 2 3 4 5 (not enough) p-value 
2 (5%) 12 (32%) 20 (54%) 2 (5%) 1 (3%) <0.001 
Chi-squared test for equal proportions used. There is evidence that the proportions are not 
equal and it appears that in general HCP’s do not feel strongly towards either case. 
 
Table 6.3: Workload attributed linked to adequate time and resources. 
 1 (adequate) 2 3 4 5 (inadequate) 
1 (too much) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 2 (100%) 
2 0 (0%) 4 (44%) 1 (11%) 3 (33%) 1 (11%) 
3 5 (25%) 2 (10%) 5 (25%) 5 (25%) 3 (15%) 
4 1 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
5 (not 
enough) 
0 (0%) 1 (100%) 0 (0%) 0 (0%) 0 (0%) 
 
The horizontal access addresses time and resource issues.  The vertical access addresses 
perceived workload issues.  Chi-squared test for linear trend p-value = 0.04 so there is 
evidence of an association between the HCP’s views on the workload attributed to 
diabetes care and the adequacy of time and resources to treat type 2 diabetes effectively. 
It appears that two HCP’s think there is inadequate time and resources to effectively treat 
patients with type 2 diabetes who also think that too much workload is attributed to 
diabetes care.  No-one indicated that they felt they had adequate time and resources and 
an adequate workload.  The majority (44%) appeared to indicate sufficient time, 
resources and workload associated with the management of people with diabetes. 
 
Table 6.4: Types of care provided by each practice. 
Practice 
  A E F G H I J K L M N 
Child S S N S S S S S N N S 
Teen S S N S S S S S N S S 
Adult S S N S S S S S S S S 
 
Elderly S S N S S S S S S S S 
Child S S U S S U S U S N U 
Teen S S U S S S S U S S U 
Adult A S A S A A A S A A A 
 
Elderly A A A S A A A S A A A 
A = All care, N = No care, S = Shared care, U = Unknown 
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Clinical Issues 
 
Professionals were asked several questions in relation to a variety of clinical issues.  They 
were first asked to rate the importance of methods of screening for diabetes and results 
are shown in Table 7.1. 
 
 
Table 7.1: Importance of methods of screening. 
 
Profession 
 All p-value† PM’s GP’s PN’s Pod’s Dietn’s DN’s p-value‡ 
Urine Testi    Urine testing 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
4 (11%) 
6 (16%) 
10 (27%) 
9 (24%) 
8 (22%) 
0.54  
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
1 (7%) 
2 (14%) 
6 (43%) 
3 (21%) 
2 (14%) 
 
3 (25%) 
3 (25%) 
1 (8%) 
3 (25%) 
2 (17%) 
 
0 (0%) 
1 (20%) 
2 (40%) 
0 (0%) 
2 (40%) 
 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
3 (75%) 
1 (25%) 
0.34 
Fasting Blood Glucose 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
2 (5%) 
0 (0%) 
1 (3%) 
4 (11%) 
30 (81%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
 
1 (7%) 
0 (0%) 
1 (7%) 
3 (21%) 
9 (64%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
12 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
4 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
1 (25%) 
0 (0%) 
0 (0%) 
0 (0%) 
3 (75%) 
0.55 
Random Blood Glucose 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
3 (8%) 
5 (13%) 
20 (53%) 
10 (26%) 
<0.001  
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
0 (0%) 
 
0 (0%) 
3 (21%) 
2 (14%) 
7 (50%) 
2 (14%) 
 
0 (0%) 
0 (0%) 
1 (8%) 
6 (50%) 
5 (42%) 
 
0 (0%) 
0 (0%) 
1 (20%) 
3 (60%) 
1 (20%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (50%) 
2 (50%) 
0.65 
Oral Glucose Tolerance 
Tests 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
 
8 (21%) 
3 (8%) 
12 (32%) 
7 (18%) 
8 (21%) 
0.25  
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (100%) 
0 (0%) 
 
 
5 (36%) 
1 (7%) 
6 (43%) 
0 (0%) 
2 (14%) 
 
 
1 (8%) 
0 (0%) 
4 (33%) 
2 (17%) 
5 (42%) 
 
 
0 (0%) 
1 (20%) 
1 (20%) 
2 (40%) 
1 (20%) 
 
 
1 (100%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
 
1 (25%) 
1 (25%) 
1 (25%) 
1 (25%) 
0 (0%) 
0.12 
Glucose 2hrs after a 
Meal 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
 
6 (17%) 
6 (17%) 
14 (39%) 
9 (25%) 
1 (3%) 
0.01  
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
 
3 (21%) 
4 (29%) 
5 (36%) 
2 (14%) 
0 (0%) 
 
 
2 (18%) 
0 (0%) 
5 (45%) 
3 (27%) 
1 (9%) 
 
 
0 (0%) 
1 (20%) 
3 (60%) 
1 (20%) 
0 (0%) 
 
 
1 (100%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
 
0 (0%) 
1 (25%) 
1 (25%) 
2 (50%) 
0 (0%) 
0.60 
† Chi-squared test for equal proportions used on proportions of each rating answer. 
‡ Chi-squared test for equal proportions used on distributions of proportions for each profession. 
 
There is evidence that the proportions are not equal regarding Fasting Blood Glucose and 
Random Blood Glucose and it appears that in general the HCP’s think these 2 are 
important. There is also evidence of differences with Glucose 2hrs after a meal but in 
general the HCP’s do not feel strongly either way. There is no evidence of any 
differences in the distributions of proportions between the profession groups. 
 
When asked regarding the importance of ongoing education and advice, Chi-squared tests 
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for equal proportions show all distributions contain significant differences except for 
Urinary Glucose Monitoring (Appendix 20). It appears that the HCP’s view the ongoing 
education and advice of all issues except this one as important. 
 
Asked about how important they rate the annual undertaking of parameters produced 
similar results (Appendix 21). Chi-squared tests for equal proportions show all 
distributions contain significant differences except for Testing Urine for Glucose. It 
appears that the HCP’s view the annual uptaking of all parameters except this and height 
as important. However, a significantly greater proportion views height as unimportant. 
 
Similar to this, in general all HCPs viewed all management issues as important 
(Appendix 22). There is evidence that the distributions for each issue do not contain 
equal proportions. There is no evidence of any differences in the distributions of 
proportions between the profession groups. 
 
In considering the importance of referrals to other HCPs, there is evidence that the 
distributions for each issue do not contain equal proportions and it appears that in general 
the HCP’s view all as important. There is no evidence of any differences in the 
distributions of proportions between the profession groups (Appendices 23). 
 
When considering the importance of recording findings and results, there is evidence that 
the distributions for each issue do not contain equal proportions and it appears that in 
general the HCP’s view medical notes and practice diabetes register as important but 
generally do not hold strong views either way on patient held records. There is no 
evidence of any differences in the distributions of proportions between the profession 
groups. 
 
Attitudes to diabetes 
 
Professionals were asked about their attitudes to diabetes in relation to other chronic 
diseases, their own confidence and linked to training.  The results are presented in Tables 
8.1 – 8.11 inclusive. 
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Table 8.1: Treatment of type 2 diabetes compared to other chronic diseases. 
 
Profession 
 All p-value† PM’s GP’s PN’s Pod’s Dietn’s DN’s p-value‡ 
Hypertension 
   1 (type 2 is easier to treat) 
   2 
   3 
   4 
   5 (type 2 is harder to treat) 
 
0 (0%) 
1 (3%) 
6 (17%) 
16 (46%) 
12 (34%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
 
0 (0%) 
0 (0%) 
3 (23%) 
6 (46%) 
4 (31%) 
 
0 (0%) 
1 (8%) 
2 (17%) 
4 (33%) 
5 (42%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
3 (75%) 
1 (25%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
2 (50%) 
1 (25%) 
0.95 
Hyperlipidaemia 
   1 (type 2 is easier to treat) 
   2 
   3 
   4 
   5 (type 2 is harder to treat) 
 
0 (0%) 
2 (6%) 
8 (23%) 
12 (34%) 
13 (37%) 
0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
 
0 (0%) 
1 (8%) 
1 (8%) 
6 (46%) 
5 (39%) 
 
0 (0%) 
1 (8%) 
5 (42%) 
1 (8%) 
5 (42%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
2 (50%) 
1 (25%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
2 (50%) 
1 (25%) 
0.74 
Angina 
   1 (type 2 is easier to treat) 
   2 
   3 
   4 
   5 (type 2 is harder to treat) 
 
0 (0%) 
3 (9%) 
15 (44%) 
7 (21%) 
9 (27%) 
0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
 
0 (0%) 
2 (15%) 
6 (46%) 
3 (23%) 
2 (15%) 
 
0 (0%) 
1 (8%) 
5 (42%) 
3 (25%) 
3 (25%) 
 
0 (0%) 
0 (0%) 
3 (75%) 
0 (0%) 
1 (25%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
1 (33%) 
0 (0%) 
2 (67%) 
0.74 
Heart Failure 
   1 (type 2 is easier to treat) 
   2 
   3 
   4 
   5 (type 2 is harder to treat) 
 
3 (9%) 
6 (18%) 
12 (35%) 
5 (15%) 
8 (24%) 
0.14  
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
 
3 (23%) 
3 (23%) 
3 (23%) 
2 (15%) 
2 (15%) 
 
0 (0%) 
2 (17%) 
6 (50%) 
2 (17%) 
2 (17%) 
 
0 (0%) 
1 (25%) 
2 (50%) 
0 (0%) 
1 (25%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
1 (33%) 
0 (0%) 
2 (67%) 
0.55 
Arthritis 
   1 (type 2 is easier to treat) 
   2 
   3 
   4 
   5 (type 2 is harder to treat) 
 
1 (3%) 
4 (12%) 
16 (47%) 
6 (18%) 
7 (21%) 
0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
 
1 (8%) 
3 (23%) 
6 (46%) 
2 (15%) 
1 (8%) 
 
0 (0%) 
1 (8%) 
8 (67%) 
3 (25%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
0 (0%) 
3 (75%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
1 (33%) 
0 (0%) 
2 (67%) 
0.12 
† Chi-squared test for equal proportions used on proportions of each rating answer. 
‡ Chi-squared test for equal proportions used on distributions of proportions for each profession. 
 
There is evidence that the distributions for each disease except heart failure do not 
contain equal proportions and it appears that in general the HCP’s view type 2 diabetes as 
harder to treat. There is no evidence of any differences in the distributions of proportions 
between the profession groups. 
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Table 8.2: Severity of type 2 diabetes by treatment. 
 
Profession 
 All p-value† PM’s GP’s PN’s Pod’s Dietn’s DN’s p-value‡ 
Diet Alone 
   1 (not at all serious) 
   2 
   3 
   4 
   5 (very serious) 
 
1 (3%) 
2 (6%) 
9 (26%) 
10 (29%) 
13 (37%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
1 (8%) 
1 (8%) 
4 (31%) 
4 (31%) 
3 (23%) 
 
0 (0%) 
0 (0%) 
4 (33%) 
2 (17%) 
6 (50%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
2 (50%) 
1 (25%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
1 (25%) 
0 (0%) 
2 (50%) 
1 (25%) 
0.86 
Tablets 
   1 (not at all serious) 
   2 
   3 
   4 
   5 (very serious) 
 
0 (0%) 
0 (0%) 
5 (14%) 
15 (43%) 
15 (43%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
3 (23%) 
7 (54%) 
3 (23%) 
 
0 (0%) 
0 (0%) 
1 (8%) 
4 (33%) 
7 (58%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (50%) 
2 (50%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
2 (50%) 
1 (25%) 
0.68 
Insulin 
   1 (not at all serious) 
   2 
   3 
   4 
   5 (very serious) 
 
0 (0%) 
0 (0%) 
1 (3%) 
8 (23%) 
26 (74%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
1 (8%) 
2 (15%) 
10 (77%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (17%) 
10 (83%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (25%) 
3 (75%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
3 (75%) 
1 (25%) 
0.53 
† Chi-squared test for equal proportions used on proportions of each rating answer. 
‡ Chi-squared test for equal proportions used on distributions of proportions for each profession. 
 
There is evidence that the distributions for each treatment method do not contain equal 
proportions and it appears that in general the HCP’s view all treatment methods as 
serious. There is no evidence of any differences in the distributions of proportions 
between the profession groups. 
 
Table 8.3: Confidence in management of type 2 diabetes. 
 
1 (very confident) 2 3 4 5 (not confident) p-value 
8 (24%) 10 (29%) 8 (24%) 7 (21%) 1 (3%) 0.14 
 
Chi-squared test for equal proportions used. There is no evidence that the proportions are 
not equal.  HCP’s appear not to feel strongly in either direction. 
 
Table 8.4: Confidence in management of type 2 diabetes linked to training. 
 
 1 (enough training) 2 3 4 5 (not enough training) 
1 (very confident) 4 (50%) 3 (38%) 1 (13%) 0 (0%) 0 (0%) 
2 0 (0%) 4 (40%) 3 (30%) 3 (30%) 0 (0%) 
3 0 (0%) 3 (38%) 2 (25%) 3 (38%) 0 (0%) 
4 1 (14%) 2 (29%) 0 (0%) 4 (57%) 0 (0%) 
5 (not confident) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (100%) 
 
Chi-squared test for linear trend p-value = 0.004 so there is evidence of an association 
between the HCP’s views on their training and their confidence in management of type 2 
diabetes. It appears that HCP’s that feel they have enough training also feel confident in 
management of the disease. 
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Table 8.5: Confidence that own therapeutic actions/ advice result in improved outcomes. 
 
1 (strongly agree) 2 3 4 5 (strongly disagree) p-value 
8 (24%) 11 (32%) 8 (24%) 6 (18%) 1 (3%) 0.09 
 
Chi-squared test for equal proportions used. There is no evidence that the proportions are 
not equal.  HCP’s appear not to feel very strongly about this although they tend to agree 
more than disagree. 
 
Table 8.6: Confidence in therapeutic actions/ advice linked to training. 
 
 1 (enough training) 2 3 4 5 (not enough training) 
1 (very confident) 3 (38%) 3 (38%) 2 (25%) 0 (0%) 0 (0%) 
2 1 (9%) 6 (55%) 1 (9%) 3 (27%) 0 (0%) 
3 0 (0%) 3 (38%) 2 (25%) 2 (25%) 1 (13%) 
4 1 (17%) 0 (0%) 1 (17%) 4 (67%) 0 (0%) 
5 (not confident) 0 (0%) 0 (0%) 0 (0%) 1 (100%) 0 (0%) 
 
Chi-squared test for linear trend p-value = 0.004 so there is evidence of an association 
between the HCP’s views on their training and their confidence that their actions/advice 
result in improved outcomes. It appears that HCP’s that feel they have enough training 
also feel confident in their actions/ advice. 
 
Table 8.7: Training capacity. 
 
Profession 
 All p-value† PM’s GP’s PN’s Pod’s Dietn’s DN’s p-value‡ 
   1 (enough training) 
   2 
   3 
   4 
   5 (not enough training) 
5 (15%) 
12 (35%) 
6 (18%) 
10 (29%) 
1 (3%) 
0.03 1 (100%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
2 (18%) 
5 (46%) 
2 (18%) 
1 (9%) 
1 (9%) 
1 (8%) 
5 (42%) 
2 (17%) 
4 (33%) 
0 (0%) 
1 (20%) 
0 (0%) 
1 (20%) 
3 (60%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (25%) 
1 (25%) 
2 (50%) 
0 (0%) 
0.65 
† Chi-squared test for equal proportions used on proportions of each rating answer. 
‡ Chi-squared test for equal proportions used on distributions of proportions for each profession. 
 
There is evidence that the proportions are not equal and that in general HCP’s do not feel 
strongly either way regarding their training. There is no evidence of any differences in 
the distributions of proportions between the profession groups. 
 
Table 8.8: Adequacy of time and resources to effectively treat people with type 2 
diabetes. 
 
1 (adequate) 2 3 4 5 (inadequate) p-value 
6 (18%) 7 (21%) 6 (18%) 8 (24%) 7 (21%) 0.98 
 
Chi-squared test for equal proportions used. There is no evidence that the proportions are 
not equal.  HCP’s appear not to feel strongly in either direction. 
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Table 8.9: Diabetic care requires a team approach. 
 
1 (strongly agree) 2 3 4 5 (strongly disagree) p-value 
23 (68%) 4 (12%) 1 (3%) 1 (3%) 5 (15%) <0.001 
 
Chi-squared test for equal proportions used. There is evidence that the proportions are not 
equal.  HCP’s appear to feel strongly that a team approach is required but 5 HCP’s have 
strongly disagreed with the idea. 
 
Table 8.10: Patient centred care can improve adherence to recommended healthcare of 
type 2 diabetic patients. 
 
1 (strongly agree) 2 3 4 5 (strongly disagree) p-value 
16 (46%) 7 (20%) 6 (17%) 3 (9%) 3 (9%) 0.003 
 
Chi-squared test for equal proportions used. There is evidence that the proportions are not 
equal.  HCP’s appear to feel strongly that patient centred care can improve adherence. 
 
Table 8.11: Patient centred care views linked to importance of recording results from 
patient held records. 
 
 1 (does improve) 2 3 4 5 (does not improve) 
1 (not important) 1 (7%) 1 (7%) 7 (47%) 3 (20%) 3 (20%) 
2 0 (0%) 0 (0%) 4 (57%) 0 (0%) 3 (43%) 
3 0 (0%) 2 (33%) 2 (33%) 1 (17%) 1 (17%) 
4 0 (0%) 1 (33%) 1 (33%) 1 (33%) 0 (0%) 
5 (very important) 0 (0%) 0 (0%) 0 (0%) 2 (67%) 1 (33%) 
 
Chi-squared test for linear trend p-value = 0.63 so there is no evidence of an association 
between the HCP’s views on the importance of patient held records and on the usefulness 
of patient centred care. 
 
Use of clinical guidelines  
 
As clinical guidelines in diabetes were among the first to be developed, professionals 
were asked about their use.  Results are presented in Tables 9.1- 9.4 inclusive. 
 
Table 9.1: Level of organisational support from practice towards use of guidelines. 
 
1 (very little) 2 3 4 5 (very high support) p-value 
1 (3%) 1 (3%) 8 (23%) 4 (43%) 10 (29%) <0.001 
 
Chi-squared test for equal proportions used. There is evidence that the proportions are not 
equal and it appears that in general HCP’s rate the level of support as high. 
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Table 9.2: Clinical guidelines affect the degree to which consultations are patient centred. 
 
Profession 
 All p-value† PM’s GP’s PN’s Pod’s Dietn’s DN’s p-value‡ 
   1 (strongly agree) 
   2 
   3 
   4 
   5 (strongly disagree) 
3 (9%) 
7 (21%) 
14 (44%) 
8 (24%) 
1 (3%) 
0.002 1 (50%) 
0 (0%) 
1 (50%) 
0 (0%) 
0 (0%) 
0 (0%) 
3 (25%) 
9 (75%) 
0 (0%) 
0 (0%) 
1 (8%) 
3 (25%) 
3 (25%) 
4 (33%) 
1 (8%) 
0 (0%) 
1 (20%) 
2 (40%) 
2 (40%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (33%) 
0 (0%) 
0 (0%) 
2 (67%) 
0 (0%) 
0.14 
† Chi-squared test for equal proportions used on proportions of each rating answer. 
‡ Chi-squared test for equal proportions used on distributions of proportions for each profession. 
 
There is evidence that the distribution does not contain equal proportions and it appears 
that in general the HCP’s generally do not agree or disagree strongly with the statement. 
There is no evidence of any differences in the distributions of proportions between the 
profession groups. 
 
Table 9.3: Benefits of clinical guidelines. 
 
 1 (not a benefit) 2 3 4 5 (very much a benefit) p-value 
Keeps you up to date with 
research findings 
0 (0%) 0 (0%) 4 (12%) 17 (50%) 13 (38%) <0.001 
Access to research findings 0 (0%) 1 (3%) 10 (29%) 14 (40%) 10 (29%) <0.001 
Saves time reading research 
papers 
1 (3%) 4 (11%) 7 (20%) 16 (46%) 7 (20%) 0.001 
Shows how to apply 
research in practice 
1 (3%) 0 (0%) 11 (31%) 15 (43%) 8 (23%) <0.001 
Aid to clinical decision 
making 
0 (0%) 0 (0%) 6 (17%) 18 (51%) 11 (31%) <0.001 
 
Chi-squared test for equal proportions used. There is evidence that the distributions for 
each benefit do not contain equal proportions and it appears that in general HCP’s rate all 
issues as beneficial. 
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Table 9.4: Barriers to clinical guidelines. 
 
 1 (not a barrier) 2 3 4 5 (very much a barrier) p-value 
No time to read 7 (20%) 1 (3%) 3 (9%) 16 (46%) 8 (23%) 0.001 
Relevant literature not 
accessible 
6 (17%) 5 (14%) 17 (49%) 6 (17%) 1 (3%) <0.001 
Lack of time to implement 
new ideas on the job 
3 (9%) 0 (0%) 16 (46%) 10 (29%) 6 (17%) <0.001 
Facilities are inadequate for 
implementation 
3 (9%) 8 (23%) 14 (40%) 8 (23%) 2 (6%) 0.01 
Organisation will not 
cooperate with 
implementation 
7 (20%) 10 (29%) 9 (26%) 6 (17%) 3 (9%) 0.37 
Ability to evaluate quality 
of research 
5 (14%) 3 (9%) 13 (37%) 7 (20%) 7 (20%) 0.09 
Little understanding of 
statistics 
4 (11%) 4 (11%) 14 (40%) 6 (17%) 7 (20%) 0.046 
Adverse effect on 
relationship with patient 
5 (14%) 8 (23%) 19 (54%) 2 (6%) 1 (3%) <0.001 
 
Chi-squared test for equal proportions used. There is evidence that the distributions for all 
barriers except two do not contain equal proportions. It appears that in general HCP’s feel 
that a lack of reading time is the greatest barrier to using clinical guidelines. 
 
Discussion 
 
Health care systems and processes of care 
 
Within this LHCC the population of people with diabetes is fully identified through use 
of computerised record systems, predominantly the GPASS system, through which 
annual recall for patient review is achieved.  For the small number of practices without 
the GPASS system, annual review is achieved through use of VISION, previous clinic 
sheets, and box file records. 
 
The number of patients registered with type 2 diabetes in this LHCC increased by 120 
people within the study period, from 1402 at baseline, to 1522 by the end of the study.  
This equates to an increase in identified prevalence of the condition of 0.2%: 2.2% at 
baseline and 2.4% in the follow up (Table 1.1). 
 
At the start of the study the majority of practices had begun to implement level 3 care, 
and by the end all practices were delivering this level of service.  Patients' experiences of 
this change in service were explored through focus group discussions and their 
perceptions are presented in the focus group section of this report.  One of the 
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requirements of level 3 care is staff attendance at accredited diabetic training which has 
been met by all practices.  Hence each practice has a named lead GP and Practice Nurse 
for diabetes care. 
 
Study Sample 
 
Forty one percent (n=576) of the population of people with type 2 diabetes were invited 
to participate in the study through the sampling strategy described in the methodology 
section, of which 140 agreed to participate (10% of the population).  In hindsight had a 
larger number been invited then a larger and more representative study sample may have 
been obtained.  However due to time constraints and the necessity to get the study 
underway reminder letters were sent to all non respondents but further recruiting was not 
undertaken. 
 
Although there is no significant difference in the mean age of the sample group and the 
population (65.4yrs and 63.8yrs respectively), there are significant differences in the 
breakdown of age categories with a higher representation of 65-74 year olds in the 
sample group and a smaller representation of under 64 year olds and over 75 year olds.  
This may be due in part to work commitments of under 64 year olds and age restrictions 
of over 75 year olds restricting ability or willingness to participate in the study. 
 
Again, a significant difference is noted in the deprivation categories of the sample and 
population groups with a higher percentage of depcats 1 to 5 represented in the sample, 
and a smaller representation of depcats 6 and 7 (Table 2.1). 
 
The percentage of patients from an Asian ethnic background in the population is 18% 
whereas that in the sample is 6%.  This is in spite of stratified sampling to ensure 
representation of this client group, and may be partially due to language barriers 
especially in the older age group. 
Due to the differences in age category, deprivation category and ethnic origin the sample 
is not fully representative of the population. 
 
Patient questionnaires 
 
Results from the SF-36 questionnaire which measures general health and well being, and 
the PAID questionnaire which is a diabetes-specific measurement of distress show no 
difference in these measures for the whole sample group between baseline and follow up 
(Table 3.1).  The only exception to this is in the score for bodily pain where a mean 
difference of –6.44 is noted (in the scale of 0-100).  Respondents were encouraged to add 
any of their own comments to these questionnaires which many did, and frequent 
reference was made to musculoskeletal conditions such as arthritis and joint replacements 
as the cause of bodily pain. 
 
The median PAID score at baseline and follow up remained stable at 13 (Table 3.2).  The 
score generated by PAID is on a scale from 0-100, with 100 representing a high level of 
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distress and 0 representing a low level of distress caused by living with diabetes.  
Therefore it would appear that within the sample there is a good level of coping with the 
condition. 
 
Appendices 1 and 2 break down questionnaire responses for females and males.  The 
only statistically significant difference is a slight worsening in the measurement of mental 
health for males (mean difference in score = -4.23) 
 
Appendices 3-6 break down responses as per age categories of respondents.  Statistically 
significant differences are highlighted in bold.  For the under 55 year old age group 
significant worsening is seen in Role limitation physical, Social function and General 
Health. 
 
No significant difference in scores was found in the 55-64 year old age group, while the 
only significant difference in the 65-74 yr old’s was in the measurement of the PAID 
score with a mean increase in score of 2.56 points. 
 
Scores from patients in the >74 age group show significant worsening in Physical 
function, Role limitation physical, Energy/Vitality and Bodily pain.  Again this may be 
due in part to co-morbidity factors such as musculoskeletal conditions.  The PAID score 
for this group also shows a mean increase of 4.51 points. 
 
Appendices 7-9 break down questionnaire results for deprivation categories 1&2, 3-5 and 
6&7.  No statistically significant differences are noted for respondents from depcats 3 to 
7.  For respondents from depcats 1&2 significant worsening is noted in Physical function, 
Role limitation physical, Energy/Vitality and Bodily pain. 
 
Patients’ clinical data 
 
This section refers to Tables 4.1-4.3 and Appendices 10- 19.  Baseline and follow up 
clinical data was obtained retrospectively from computer and manual records.  Baseline 
data was taken from the nearest record to January 2002, and follow up data from the 
nearest record to December 2003. 
 
Statistically significant improvements for the entire sample were found in levels of 
random blood glucose, cholesterol, HDL, systolic blood pressure and diastolic blood 
pressure. 
 
Table 4.2 outlines other clinical results.  As can be seen in the table there is a significant 
improvement in smoking status and levels of physical activity for the sample group as a 
whole.  There is also a significant worsening in the presence of the right pedal pulse.  
There were no statistically significant findings in referral to smoking cessation clinics or 
exercise classes. There were no prescriptions given for nicotine replacement therapy 
(NRT).  It is acknowledged however that concomitantly with this study, there was a local 
initiative through pharmacies to provide NRT free for 3 months. This did not result in any 
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ongoing prescriptions beyond that time. 
 
In the breakdown of results for females it can be seen that although random blood 
glucose, cholesterol, HDL, and diastolic blood pressure significantly improved, there is 
no significant change in systolic blood pressure or quality of life issues (Appendix 11).  
Systolic blood pressure remains borderline at both time points: 141.92mmHg at baseline 
and 139.02mmHg at follow up. 
 
Statistically significant paired clinical results for males does not include absence of right 
pedal pulse (Appendix 12) although 10% of pairs show absence of same at follow up. 
 
For those in the <55 yr age group the statistically significant improvements were seen in 
random blood glucose levels, total cholesterol and smoking status (Appendix 13). 
Appendix 14 shows results for the 55-64 yr age group – statistically significant 
improvement is seen in HDL levels, and Body mass Index sees a statistically significant 
worsening from a mean of 30.5 to a mean of 31.6. 
 
In the 65-74 age group the statistically significant improvements were seen in random 
blood glucose, total cholesterol, HDL and diastolic blood pressure (Appendix 15) 
whereas in the >75 age group the only statistically significant differences were 
improvements in total cholesterol and in systolic blood pressure (Appendix 16). 
 
Appendix 17 shows that the only statistically significant differences for those in 
deprivation categories 1 & 2 are improvements in random blood glucose, total cholesterol 
and HDL.  This is also true for those in deprivation categories 3 to 5 (Appendix 18).  
However results for depcats 6&7 also show a statistically significant improvement in 
HbA1c levels (mean of 8.58 at baseline and 7.74 at follow up), and also in random blood 
glucose, total cholesterol and smoking status (Appendix 19). 
 
Table 4.3 shows the percentages of results which were within the range of recommended 
guidelines at baseline and at follow up.  It can be seen that there is a statistically 
significant improvement in the results for total cholesterol and blood pressure in line with 
recommended guidelines. 
 
Medication prescriptions 
 
While certain clinical parameters had improved, others showed statistical significance.  
On interrogating the data to determine if there had been increased prescriptions of new 
drugs or increased prescription of current dosages, several area were identified (Tables 
5.1-5.9). 
 
There was a significant increase in the prescribing dose of Gliclazide to patients that were 
on the drug at both baseline and follow up.   There was a statistically significant increase 
in the prescribing of Metformin.  This was true for the increase in dose and the frequency 
of prescription. 
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While there was an increase in the number of patients who required insulin from baseline 
to follow up, this was not statistically significant. 
 
There was a significant increase in the proportion of patients that were prescribed some 
form of diabetes medication and could suggest that this was due to improved 
management from the new service. There was a statistically significant difference 
between baseline and follow up of the number of diabetes drugs prescribed to patients. 
 
There was statistical significance in the prescribing of all Ace inhibitors, ARAs, 
hypertensive drugs, statins and aspirin. 
 
When linked to clinical parameters, prescriptions to address hypertension and cholesterol 
were the only statistically significant results. 
 
Hence, the prescription of drugs is improving clinical parameters around hypertension 
and the treatment of cholesterol.  While diabetes related drugs have shown increased 
usage, there is no causal link between this and the improved HbA1c results noted.   
 
It must be noted however that although there was an improvement of HbA1c, there was 
no increase of BMI. Normally, when a person improves their glycaemic control, this is at 
the expense of their weight gaining.  While not statistically significant, there may be 
benefit in a less aggressive approach to improvement of glycaemic control if it maintains 
body weight. 
 
Health care professionals perceptions 
 
Statistical analysis of the healthcare professionals' questionnaire highlighted a number of 
strong perceptions (Table 7.1, Appendices 20-24).  Overall the responses show a high 
level of satisfaction with the new system of care delivery for patients with Type 2 
diabetes.  A patient centred, and team approach is perceived as very important, as well as 
tight management in terms of annual monitoring and advice.  The management of 
diabetes is perceived as harder than some other chronic conditions, and diabetes-specific 
training is valued for increasing confidence in the management of it.  Referral to other 
professionals is valued as important also.    
 
Conclusions 
 
The introduction of community based care for people with type 2 diabetes within this 
LHCC is not compromising individuals’ health status or care management.  Indeed 
significant improvements are noted in key clinical indices including blood pressure and 
cholesterol levels.  Patients’ general health status and coping with diabetes remain largely 
unchanged. 
 
Medications were prescribed to address clinical issues of diabetes, hypertension, 
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cholesterol and when analysed according to clinical parameters demonstrated links with 
improvements of blood pressure and cholesterol levels. 
 
Health care professionals perceive type 2 diabetes to be a serious condition and value the 
importance of tight clinical management.  Diabetes-specific training was valued, and 
there is overall a high level of satisfaction among health care professionals with the new 
system of care. 
 
Patients’ perspectives of the new service will now are discussed in the following section: 
focus group sub study. 
 
 
Focus group sub study: Perceptions of service users 
 
Aim 
 
To explore the perceptions and experiences of adults with type 2 diabetes of a 
restructuring of their diabetes service from secondary to primary care and of living with 
diabetes. 
 
Sample 
 
The sample was acquired from the Greater Shawlands LHCC which consisted of 14 GP 
practices.  It is recommended that a sample for qualitative research is not prespecified in 
strict terms lest important data sources be overlooked and so purposive sampling is often 
used.  The aim of this study was to explore service users’ perceptions and experiences so 
a range of participants was sought to represent different ages, genders and ethnic 
backgrounds in order to explore a range of perspectives.  With this in mind people were 
selected to meet identified criteria from GP’s diabetes registers. Inclusion criteria were 
adults with type 2 diabetes for at least 2 years.  Exclusion criteria were people who had 
type 1 diabetes or who were younger than 18 years. Fourteen people were selected from 
each register and in total, 35 people consented to take part in the focus group study. 
 
Methodology 
 
Patients were selected from GP practices and focus groups were held per practice. The 
focus group discussions were conducted in two phases – five in the autumn of 2003 with 
participants (n= 23) from five GP practices who were in the early stages of implementing 
the new diabetes service, and a further three in the autumn of 2004 with participants 
(n=12) from three GP practices who had been providing the new service for the longest 
time (approximately two years).  The sample was sent an invitation letter and this was 
followed up a week later with a telephone call from one of the researchers to acquire 
consent and answer any questions.  
 
Concurrent data collection and thematic analysis was conducted by 3 researchers for 
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credibility and reliability.  The study used a phenomenological approach, and 
interpretivism was used to analyse the qualitative data generated by the focus groups.  
Each discussion lasted for between 60 and 90 minutes and was moderated by a lead 
researcher. A topic guide was used as a prompt to encourage discussion and flexibility 
was also employed to let participants direct the conversation to matters that interested and 
concerned them.  Further areas for exploration were thereby identified for subsequent 
groups.  A research assistant was present along with the lead researcher to help with 
logistical matters and take field notes.   
 
Analysis 
 
Tape recordings of each focus group were transcribed verbatim, and the transcripts, along 
with the tapes and field notes, formed the findings.   
 
The data was analysed both during and after collection.  The topic guide served as an aid 
to analysis.  Thematic analysis was used whereby sections of transcripts which related to 
the areas of topic under study were pulled together, and thereafter separated into sections 
and categories.  Analysis of the content of the first three focus groups indicated that 
saturation, which is the point at which further observations yield minimal or no new 
information, had not been reached.  Therefore a further 2 groups were planned and 
conducted in this initial phase and saturation reached.  In the second phase of the study 
saturation was achieved early after 2 focus groups but a 3rd was conducted for 
confirmation.   
 
The 5 earlier focus groups were analysed in depth together and thereafter the 3 latter 
groups.  It became clear that there was no new material in the latter groups and hence the 
findings are presented together. 
 
Investigator triangulation was used to validate findings.  Member checking was also 
employed to validate findings and to improve the rigour of the research.   All participants 
were given a written summary of the findings and were invited to attend a feedback 
session where findings were presented.  Participants were encouraged to make comments 
and were provided with a response sheet to make anonymous written comments if they so 
wished.  This process proved useful in clarifying and confirming the findings.   
 
Results 
 
Six major themes emerged from the analysis: Impact of organisational change, Location 
and process of care, Perceptions of care, Living with diabetes, Motivation to participate 
in care and Education and information.  
 
Impact of organisational change 
 
Various attitudes towards the change in service became evident, such as acceptance, 
cautious expectation, and also a positive outlook: 
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“As long as you are still getting the same service, I don’t see why it should bother 
anybody.”  
 
“ …it is important to know that you have other options if you are not happy.  But 
I’ve always found the practice to be very good so I would certainly come along 
and see what happens.”   
 
The view was expressed that the driver for change was service improvement, and 
familiarity with healthcare staff was appreciated: 
 
 “I was told it was to provide a better service.” 
  
 “…you know your own nurse and you know the doctor, and they give you a 
 better chance…” 
 
It was also perceived by some that the reasons for the change in service may be financial: 
 
“… is this part of the larger Glasgow plan to reduce the number of hospitals and 
so on?” 
 
Location and Process of Care 
 
For both models of care participants discussed factors that contributed to levels of 
convenience and comfort such as location, numbers of other people at clinics, and 
waiting times involved at appointments. 
 
The new service was welcomed for its convenience, with smaller numbers of other 
people present at the clinics and with more time available to spend in consultation. 
 
 “..it’s obviously far more convenient…you don’t have the numbers that you 
 have at the hospital.  Here…it just runs through.” 
“When you went to the hospital…you sat in a waiting room.  And you went back 
and forward and back and forward.  You’re talking a full morning or afternoon.”  
  
Perceptions of care 
 
Within the new model participants felt more relaxed with healthcare staff.  They felt able 
to ask questions and discuss concerns, and were confident of referral to specialists if it is 
necessary: 
 
“..it’s faces that you know and I feel quite relaxed and I feel I can ask her things 
and she’s very nice.”   
 
“They know me.  It’s on a more personal basis.” 
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“I know they can refer me to the hospital if they’re not sure about something.” 
 
In contrast some found the hospital setting intimidating, and felt rushed and unable to ask 
questions: 
 
“I think when you go to the hospital, it’s just a face, with a name. … they are only 
interested in one thing, and that’s what you’ve got, whether it’s diabetes or it’s 
something else, then that’s what they stick to. …a lot of people are frightened to 
go to the hospital, and would rather go to their own GP.”  
 
However, the hospital service was perceived as specialised, up to date and reassuring:  
 
‘I found the hospital very good…because they gave me a great deal of 
information and a lot of support to begin with at the annual checks… they are 
pretty up to date.”  
 
“I felt I was being very carefully looked after.”   
 
Concerns were raised by some participants about the accessibility of expertise and 
information in the general setting:  
 
“ Just one concern I have was that…you feel that the hospital is a centre of 
expertise and you kind of worry a wee bit…” 
 
These concerns were balanced with the view that primary healthcare professionals had 
undergone further educational diabetes training in order to provide the new service:  
 
 “..they are pretty well informed…out in the community.” 
  
 “I would ask the nurse, cause I know now she’s up in it, very well qualified to 
 talk about it.” 
 
Concerns also touched upon specific aspects of service provision that people valued in 
the old model and did not wish to lose such as annual check, and provision of a feedback 
letter with test results:   
 
 “ … if you’re moving it from a centre and you’re offering what is perceived to be 
a better service, in your own practice, then you’ll be looking for something more 
… more frequently rather than annually.”  
 
“… you got a letter back from the hospital telling all of your results.  You don’t 
get that from the (GP).”   
 
 
Lindsay G, McDowell J, McPhail K (2006) An evaluation of the impact of the Glasgow 
Diabetes project for healthcare for patients with type 2 diabetes. Nursing & Health Care, 
University of Glasgow, Glasgow ISBN: 9780852618233 
 
39 
Living with Diabetes 
 
Participants expressed awareness of the seriousness of diabetes and discussed the impact 
of being diagnosed with the condition: 
 
 “...my initial reaction was ‘why me’.” 
 
“You automatically get a shock, and you immediately think about needles and 
insulin..” 
 
The impact of diabetes on their lifestyle was discussed: 
  
“We have to face it...we have no other option. ...It’s a big thing.” 
“It dawns on you after quite a short time that you’ve got this for the rest of your 
life.  ... You’ve got to do something about it.”  
 
When asked what they perceived to be the worst part of living with diabetes some     
participants answered: 
   
“The initial realisation, getting hit with it, and taking it all in and having to 
change your lifestyle and the eating habits and all the rest of it.”  
 
Motivation to Participate in Care 
 
Participants emphasised the central role of “self” in managing the condition:  
 
“...yourself is the person that should be controlling it...it lies with you, how you’re 
diabetes goes.” 
 
“You have to be proactive.” 
 
“I think the bottom line must be as an individual, you must look after yourself.” 
 
They also discussed the need for support from others in the form of understanding and 
information: 
 
“..with advice, help and support you adjust to it.” 
 
“If you are wanting to work in partnership with your doctor and control your own 
condition…then you want more up to date information.”   
Education and Information 
Formal education sessions which were provided under the hospital model of care were 
valued highly although due to the timing of meetings were not accessible to people 
working office hours.  Education sessions in the new service had not been fully 
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established but were considered to be desirable, especially for people newly diagnosed, 
and with a peer support slant:   
“I think you’ve got to have something. I think newly diagnosed people obviously 
do require a fair degree of material upfront.”  
“..we gain a lot from each other when we talk to each other.”  A clear point of 
contact in the new service for information and expertise was also desired. 
Discussion of completed project 
 
The whole project aimed to evaluate the impact of the Glasgow Diabetes Project on 
healthcare for people with type 2 diabetes.  There were 3 primary objectives and 5 
secondary objectives that will be addressed in the discussion.  These are presented on 
page 5. 
 
Each of the practices (n=14) had an electronic system for identifying people with 
diabetes.  Most practice sued GPASS although a few used VISION.  These IT systems 
identify when period reviews are required and maintain a record of medications 
prescribed and clinical management.  
 
People still had contact with health care professionals in both primary and secondary care 
(Tables 5.10; 5.11). The goal of the project was that people with stable type 2 diabetes 
would be managed solely within primary care and only referred to secondary care for 
specialist input.  There was evidence that the change process was still ongoing.  This may 
not be unexpected in a transition period.  This appeared to look, from the case notes, to be 
ongoing care that was already established as opposed to new referrals to secondary care. 
 
HbA1c improved but not statistically significant however the random blood glucose 
improved statistically significantly (Table 4.1).  The overall improvement in diabetes 
control, while not statistically significant was not at the expense of weight gain which is 
the normal expected result.  Hence, the improvement is clinically beneficial for patient 
care. 
 
There was a significant increase in the prescribing of Gliclazide and Metformin.  While 
there are newer hyperglyaecemic agents e.g.  it is interesting to note that the well 
established medications were the drugs of choice.  The history of metformin has changed 
over the years and it is good to see its increased usefulness.  Current guidelines indicate 
that it should be the first point of management in people with type 2 diabetes. However 
its benefits are greater than for the newly diagnosed and this is evidenced here.  We 
cannot make an inference between this prescribing and improvement in HbA1c. 
There was a statistically significant improvement in the blood pressure and cholesterol 
levels with a number achieving target levels (Table 4.3, 4.7). The related factor may be 
the statistically significant increase in the prescribing of all Ace inhibitors, Angiotensin 
Receptor Antagonists, hypertensive drugs, statins and aspirin (Tables 5.5; 5.6;5.7; 5.8; 
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5.9). 
 
There was a statistically significant improvement in the number of people who stopped 
smoking during this time (Table 4.2). This significance was seen in the male population 
under the age of 55 years. It was discovered towards the end of the project that during 
this data collection period The Starting Fresh Pharmacy Project took over the prescribing 
of Nicotine Replacement Therapy free with the maximum duration of the course being 12 
weeks. During this time, the LHCC employed a smoking cessation co-ordinator who ran 
clinics in several locations.  It is unknown if people took up this offer.  However, it could 
be assumed that if someone commenced nicotine replacement therapy and found it 
beneficial, they would ask their GP for a prescription for continuation.  It is noted that 
there were no prescriptions for nicotine replacement therapy for any patients in this study 
or any record of health care interventions/advice to promote smoking cessation.     
 
There was a statistically significant improvement in the number of people who improved 
their exercise levels during this time.  Only a few people were referred to an exercise 
referral scheme   (page 18) and hence there is no cause and effect evident. The few 
referrals made for exercise were from the one practice.  
 
Patients’ appreciated the new service because of its convenience and patient centered 
focus.  They had confidence in the health care team for referral to specialist services if 
needed.  There were very few default rates from both primary and secondary care 
although rates were higher at the hospital clinic (Tables 5.10; 5.11).  
 
Patients’ general health did deteriorate but due to other conditions, not diabetes. In the 
whole study population, although there was a trend for general lower health status this 
was only significant in relation to bodily pain (Table 3.1) People indicated that this was 
due to other concomitant chronic illnesses.  Men had a significant deterioration in their 
mental health score. Women, across all ages, remained the same in all the domains of 
health (Appendices 1, 2).  There was no statistically significant reduction in reported 
deterioration in health status for patients in the highest area of economic deprivation 
(Appendix 9).  There were statistically significant deteriorations in those people from the 
most affluent areas (Appendix 7).  It is noted that those in depcat areas 6 and 7 had lower 
baseline health scores compared to those in depcat 1 and 2 however, those in depcat areas 
6 and 7 did not deteriorate. 
 
On subgroup analysis there was statistically significant deterioration in several health 
domains for the under 55 year olds and the over 74 year olds regardless of gender.  This 
may reflect the challenges facing the normally economically active population and the 
health issues associated with ageing.   
 
Patients’ attitudes to coping with diabetes stayed the same no matter where their care was 
delivered.  They expressed concern that their annual review would be extended beyond a 
year due to increasing number of people with diabetes. Patients stated that they would 
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like more education about self management of diabetes.  Some patients had experience of 
a 6 week programme offered from secondary care for people newly diagnosed and 
referred to secondary care. The need for education and information to be available was 
seen as being particularly strong at diagnosis, but also ongoing, and a clear point of 
contact for such was sought. They highly valued access to up to date information and 
expertise to enable them to manage their own condition. Patients also requested that they 
be given a written record of their results so that they could compare these with previous 
years. 
Overall the participants who took part in this focus group study appreciated the change in 
service delivery.  Their local GP surgery was more geographically convenient and they 
felt that they were ‘known’ by the staff in the GP surgery where they also received 
holistic care.  This was in contrast to the hospital where they felt that they were seen only 
for their diabetes and that time constraints worked against building up relationships with 
the healthcare professionals.  Some concerns were aired around the generalist versus 
specialist debate.  In discussion, it was acknowledged that the primary care professionals 
had undergone additional educational preparation and hence they had confidence in the 
referral system should individual people require this.   
As people volunteered to take part in focus groups, it is not surprising that they all had a 
very strong internal locus of control about their diabetes.  All stated that they personally 
were primarily responsible for their diabetes management and that it was not health care 
professionals who were responsible.   
Interestingly no new findings were found between patients perceptions in the early stages 
of the new service and also 2 years on.  This may indicate that patients are satisfied with 
the new delivery of service, albeit may have had minimal contact due to the annual nature 
of the clinics.  Alternatively, from above, it appears to be that the service is still 
undergoing change in practice and people, in addition to being seen in secondary care, are 
also being seen in primary care and so could be are seeing health care professionals more 
frequently. 
 
Professionals' perceptions questionnaire showed a high level of satisfaction with the new 
service. In general, professionals view type 2 diabetes harder to treat when compared 
with people who have hypertension, hyperlipidaemia, angina, heart failure, arthritis. 
Conclusion 
In conclusion this study demonstrates that for these people, the change in service delivery 
is welcomed provided patient requests for education and a record of their results are put 
in place and an annual review maintained.  In addition it is evident that the new model of 
care is beneficial with significant improvements in a range of clinical indices of good 
diabetes management.  However, because patients were still being seen by both systems 
of care it is difficult to differentiate the impact of each separate service. 
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Recommendations for practice 
1. Patient education programmes are initiated for the newly diagnosed in the first 
instance in primary care. 
2. Ongoing patient education in primary care is made available. 
3. Patients are given a record of their key clinical parameters at each visit and 
encouraged to meet targets 
4. An annual review of clinical parameters is maintained. 
5. That there is a more proactive approach to discharging patients from secondary 
care. 
6. Advice about smoking cessation or referral to specialist services should be 
recorded in clinical notes. 
7. Good management was observed within GP practices and efforts to sustain and 
develop this activity should be supported. 
8. The project should be re-evaluated in 5 years time to ensure that the transition 
period has been completed and that there is no duplication of service delivery. 
Dissemination 
Findings have been disseminated through various means throughout the course of the 
study including poster presentations and concurrent sessions at conferences.  The focus 
group findings were presented at a concurrent session at the Caring for Glasgow Nursing 
Conference in May 2004.  Findings of the clinical data study were also presented at a 
concurrent session at the Annual International Nursing Research conference in Belfast in 
March 2005.  At this same conference a poster presentation was made of the focus group 
study also.  In April 2005, a presentation of the clinical data was made in the Division of 
Nursing and Midwifery, University of Glasgow, and in May 2005 to the Greater 
Shawlands LHCC.   
Articles are in the process of being written for publication that are at various stages of 
acceptance by journals.  
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 Paired results for females: Appendix 1 
 
 No Pairs Baseline† 1 yr follow up† Mean difference‡ p-value 95% CI for diff 
Physical Function  36 73 (46 - 80) 63 (46 - 80) -4.72 0.25 -12.83 to 3.39 
Role Limitation Physical 36 50 (0 - 100) 25 (0 - 100) -9.03 0.24 -24.31 to 6.26 
Role Limitation Mental 36 67 (25 - 100) 100 (0 - 100) -3.69 0.60 17.80 to 10.41 
Social Function 36 78 (56 - 100) 78 (56 - 100) -3.08 0.48 -11.87 to 5.71 
Mental Health 36 66.11 (22.54) 67.67 (21.69) 1.56 0.46 -2.65 to 5.77 
Energy / Vitality 36 47.50 (24.86) 47.36 (21.76) -0.14 0.97 -7.10 to 6.83 
Bodily Pain 36 67.33 (25.71) 59.00 (29.01) -8.33 0.08 -17.60 to 0.94 
General Health 36 53.36 (26.44) 52.58 (22.43) -0.78 0.80 -7.05 to 5.50 
PAID 38 13 (5 – 27) 13 (6 - 27) 1.05 0.55 -2.44 to 4.55 
† Figures are mean (st dev) for mental health to general health and median (interquartile range) for physical function to 
social function and PAID [due to skewed distributions]. 
‡ Figures are mean for all [as distributions of differences are not skewed]. 
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 Paired results for males: Appendix 2 
 
 No Pairs Baseline† 1 yr follow up† Mean difference‡ p-value 95% CI for diff 
Physical Function  52 75 (50 - 95) 78 (41 - 90) -2.98 0.24 -8.01 to 2.05 
Role Limitation Physical 52 100 (0 - 100) 75 (0 - 100) -7.21 0.20 -18.43 to 4.01 
Role Limitation Mental 52 100 (33 - 100) 100 (33 - 100) 1.27 0.82 -9.92 to 12.46 
Social Function 52 89 (59 - 100) 78 (44 - 100) -5.79 0.08 -12.47 to 0.67 
Mental Health 52 75.38 (20.20) 71.15 (20.90) -4.23 0.02 -7.74 to -0.72 
Energy / Vitality 52 54.13 (23.72) 49.90 (23.67) -4.23 0.09 -9.11 to 0.65 
Bodily Pain 52 72.50 (28.36) 67.37 (29.40) -5.13 0.12 -11.56 to 1.29 
General Health 52 55.79 (22.67) 51.10 (23.58) -4.69 0.09 -10.14 to 0.75 
PAID 56 12 (6 – 23) 13 (6 - 27) 2.03 0.17 -0.90 to 4.96 
† Figures are mean (st dev) for mental health to general health and median (interquartile range) for physical function to 
social function and PAID [due to skewed distributions]. 
‡ Figures are mean for all [as distributions of differences are not skewed]. 
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Paired results for <55yrs: Appendix 3 
 
 No Pairs Baseline† 1 yr follow up† Mean difference‡ p-value 95% CI for diff 
Physical Function  15 75 (55 - 100) 80 (20 - 95) -9.33 0.06 -19.09 to 0.42 
Role Limitation Physical 15 100 (0 - 100) 50 (0 - 100) -16.67 0.045 -32.94 to -0.40 
Role Limitation Mental 15 100 (0 - 100) 33 (0 - 100) -6.67 0.57 -31.03 to 17.69 
Social Function 15 89 (33 - 100) 67 (11 - 100) -15.53 0.006 -25.90 to -5.17 
Mental Health 15 59.47 (28.72) 56.27 (26.98) -3.20 0.41 -11.37 to 4.93 
Energy / Vitality 15 41.67 (27.50) 41.33 (26.69) -0.33 0.92 -6.99 to 6.34 
Bodily Pain 15 68.27 (25.20) 57.87 (37.22) -10.40 0.19 -26.54 to 5.74 
General Health 15 50.27 (26.45) 41.40 (6.66) -8.67 <0.001 -12.96 to -4.77 
PAID 18 25 (11 - 46) 23 (13 - 43) 0.69 0.86 -7.60 to 8.99 
† Figures are mean (st dev) for mental health to general health and median (interquartile range) for physical function to 
social function and PAID [due to skewed distributions]. 
‡ Figures are mean for all [as distributions of differences are not skewed]. 
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Paired results for 55-64 yrs: Appendix 4 
 
 No Pairs Baseline† 1 yr follow up† Mean difference‡ p-value 95% CI for diff 
Physical Function  17 75 (43 - 90) 80 (63 - 93) 8.52 0.19 -4.57 to 21.63 
Role Limitation Physical 17 100 (13 - 100) 100 (50 - 100) 11.77 0.29 -11.01 to 34.54 
Role Limitation Mental 17 100 (46 - 100) 100 (67 - 100) 6.35 0.46 -11.56 to 24.27 
Social Function 17 89 (56 - 100) 78 (67 - 100) 3.88 0.54 -9.22 to 16.99 
Mental Health 17 66.82 (22.13) 67.53 (20.09) 0.71 0.79 -4.84 to 6.26 
Energy / Vitality 17 52.35 (27.96) 52.35 (26.52) 0.00 1.00 -13.51 to 13.51 
Bodily Pain 17 66.06 (30.15) 68.06 (25.83) 2.00 0.74 -10.55 to 14.55 
General Health 17 52.29 (24.84) 55.82 (29.43) 3.53 0.48 -6.76 to 13.81 
PAID 18 16 (8 – 37) 13 (9 - 36) -2.36 0.39 -8.04 to 3.32 
† Figures are mean (st dev) for mental health to general health and median (interquartile range) for physical function to 
social function and PAID [due to skewed distributions]. 
‡ Figures are mean for all [as distributions of differences are not skewed]. 
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Paired results for 65-74 yrs: Appendix 5 
 
 No Pairs Baseline† 1 yr follow up† Mean difference‡ p-value 95% CI for diff 
Physical Function  39 75 (50 - 90) 70 (30 - 90) -2.69 0.40 -9.13 to 3.75 
Role Limitation Physical 39 50 (0 - 100) 50 (0 - 100) -4.49 0.51 -18.26 to 9.29 
Role Limitation Mental 39 67 (33 - 100) 100 (0 - 100) 1.49 0.81 -10.94 to 13.91 
Social Function 39 89 (67 - 100) 89 (0 - 100) -1.44 0.71 -9.08 to 6.21 
Mental Health 39 75.28 (18.14) 73.64 (19.13) -1.64 0.47 -6.24 to 2.96 
Energy / Vitality 39 52.05 (23.22) 51.15 (20.82) -0.90 0.73 -6.17 to 4.37 
Bodily Pain 39 70.41 (29.39) 65.33 (28.26) -5.08 0.18 -12.51 to 2.36 
General Health 39 56.74 (24.60) 53.97 (20.81) -2.77 0.46 -10.25 to 4.71 
PAID 40 10 (5 – 17) 11 (5 - 22) 2.56 0.045 0.07 to 5.06 
† Figures are mean (st dev) for mental health to general health and median (interquartile range) for physical function to 
social function and PAID [due to skewed distributions]. 
‡ Figures are mean for all [as distributions of differences are not skewed]. 
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Paired results for >74 yrs: Appendix 6 
 
 No Pairs Baseline† 1 yr follow up† Mean difference‡ p-value 95% CI for diff 
Physical Function  17 65 (45 - 78) 45 (23 - 75) -13.24 <0.001 -19.66 to -6.81 
Role Limitation Physical 17 50 (13 - 100) 0 (0 - 63) -27.94 0.013 -49.20 to -6.68 
Role Limitation Mental 17 100 (17 - 100) 67 (0 - 100) -7.82 0.52 -33.20 to 17.55 
Social Function 17 78 (62 - 95) 67 (56 - 95) -11.12 0.10 -24.40 to 2.16 
Mental Health 17 78.59 (16.55) 74.82 (16.96) -3.74 0.13 -8.77 to 1.25) 
Energy / Vitality 17 57.65 (18.63) 46.76 (19.76) -10.88 0.04 -21.05 to -0.71 
Bodily Pain 17 76.53 (21.54) 62.00 (29.30) -14.53 0.03 -27.13 to -1.93 
General Health 17 56.82 (21.68) 51.47 (15.18) -5.35 0.13 -12.53 to 1.82 
PAID 18 6 (3 - 13) 9 (3 - 22) 4.51 0.02 0.76 to 8.27 
† Figures are mean (st dev) for mental health to general health and median (interquartile range) for physical function to 
social function and PAID [due to skewed distributions]. 
‡ Figures are mean for all [as distributions of differences are not skewed]. 
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Paired results for depcats 1&2: Appendix 7 
 
 No Pairs Baseline† 1 yr follow up† Mean difference‡ p-value 95% CI for diff 
Physical Function  24 75 (55 - 89) 75 (51 - 84) -5.21 0.04 -10.09 to -0.33 
Role Limitation Physical 24 100 (50 - 100) 50 (6 - 100) -26.04 0.01 -46.09 to -5.99 
Role Limitation Mental 24 100 (33 - 100) 100 (42 - 100) -2.38 0.80 -21.63 to16.88 
Social Function 24 100 (78 - 100) 89 (59 - 100) -8.79 0.06 -17.96 to 0.38 
Mental Health 24 81.00 (12.27) 77.50 (12.25) -3.50 0.06 -7.20 to 0.20 
Energy / Vitality 24 62.71 (16.22) 54.38 (20.97) -8.33 0.02 -15.26 to -1.41 
Bodily Pain 24 79.29 (19.99) 67.63 (23.71) -11.67 0.03 -21.70 to -1.63 
General Health 24 64.13 (20.61) 55.08 (18.68) -9.04 0.02 -16.47 to -1.62 
PAID 24 9 (4 - 13) 9 (4 - 18) 2.29 0.11 -0.54 to 5.13 
† Figures are mean (st dev) for mental health to general health and median (interquartile range) for physical function to 
social function and PAID [due to skewed distributions]. 
‡ Figures are mean for all [as distributions of differences are not skewed]. 
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Paired results for depcats 3-5: Appendix 8 
 
 No Pairs Baseline† 1 yr follow up† Mean difference‡ p-value 95% CI for diff 
Physical Function  41 75 (55 - 88) 75 (48 - 88) -3.05 0.23 -8.15 to 2.05 
Role Limitation Physical 41 100 (75 - 100) 100 (75 - 100) 0.61 0.92 -11.93 to 13.15 
Role Limitation Mental 41 75 (29 - 100) 100 (17 - 100) 6.29 0.25 -4.59 to 17.17 
Social Function 41 89 (56 - 100) 89 (56 - 100) 0.51 0.88 -6.80 to 7.82 
Mental Health 41 70.73 (22.99) 70.63 (22.17) -0.10 0.96 -4.05 to 3.85 
Energy / Vitality 41 51.10 (24.81) 50.24 (23.23) -0.85 0.74 -5.94 to 4.24 
Bodily Pain 41 70.51 (27.81) 67.27 (28.32) -3.24 0.35 -10.21 to 3.72 
General Health 41 55.63 (21.85) 53.63 (23.91) -2.00 0.40 -6.79 to 2.79 
PAID 42 13 (5 – 27) 14 (6 - 34) 1.28 0.44 -2.05 to 4.61 
† Figures are mean (st dev) for mental health to general health and median (interquartile range) for physical function to 
social function and PAID [due to skewed distributions]. 
‡ Figures are mean for all [as distributions of differences are not skewed]. 
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Paired results for depcats 6&7: Appendix 9 
 
 No Pairs Baseline† 1 yr follow up† Mean difference‡ p-value 95% CI for diff 
Physical Function  23 50 (15 - 90) 45 (10 - 85) -3.26 0.64 -17.31 to 10.79 
Role Limitation Physical 23 25 (0 - 100) 0 (0 - 100) -4.35 0.57 -19.86 to 11.17 
Role Limitation Mental 23 67 (0 - 100) 33 (0 - 100) -11.65 0.22 -30.89 to 7.59 
Social Function 23 67 (33 - 89) 56 (22 - 78) -9.65 0.11 21.62 to 2.31 
Mental Health 23 63.30 (23.25) 60.00 (23.57) -3.30 0.35 -10.43 to 3.82 
Energy / Vitality 23 40.22 (25.78) 40.65 (22.58) 0.44 0.93 -10.14 to 11.01 
Bodily Pain 23 60.87 (30.60) 54.17 (35.12) -6.70 0.30 -19.78 to 6.39 
General Health 23 43.57 (27.75) 44.74 (24.85) 1.17 0.83 -9.83 to 12.18 
PAID 28 14 (8 – 35) 13 (9 - 33) 1.61 0.54 -3.69 to 6.90 
† Figures are mean (st dev) for mental health to general health and median (interquartile range) for physical function to 
social function and PAID [due to skewed distributions]. 
‡ Figures are mean for all [as distributions of differences are not skewed]. 
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Overall clinical results that have increased, decreased or stayed the same: Appendix 10 
 
 No Pairs Decreased Same Increased 
  N (%) Mean Diff N (%) N (%) Mean Diff 
HbA1c 113 61 (54%) -1.52 3 (3%) 49 (43%) 1.32 
RBG 56 44 (79%) -4.14 0 (0%) 12 (21%) 2.55 
Creatinine 109 63 (58%) -14.48 3 (3%) 43 (39%) 29.07 
Cholesterol 102 72 (71%) -1.11 5 (5%) 25 (25%) 0.58 
HDL 71 12 (17%) -0.19 11 (16%) 48 (68%) 0.38 
Systolic BP 130 75 (58%) -19.87 7 (5%) 48 (37%) 17.29 
Diastolic BP 130 81 (62%) -12.10 9 (7%) 40 (31%) 8.80 
Weight 121 64 (53%) -4.19 16 (13%) 41 (34%) 5.11 
BMI 120 46 (38%) -2.04 27 (23%) 47 (39%) 2.13 
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Clinical paired results for females: Appendix 11 
 
 No Pairs Baseline† 1 yr follow up† Mean difference p-value 95% CI for diff 
HbA1c 45 8.02 (1.89) 7.76 (1.46) -0.25 0.37 -0.81 to 0.31 
RBG 20 12.83 (4.82) 8.49 (3.61 -4.34 <0.001 -5.99 to -2.69 
Creatinine 45 82.76 (18.60) 79.80 (20.37) -2.96 0.31 -8.73 to 2.81 
Cholesterol 39 5.09 (1.08) 4.53 (0.98) -0.56 0.001 -0.88 to -0.23 
HDL 28 1.31 (0.40) 1.59 (0.80) 0.27 0.04 0.02 to 0.52 
Systolic BP 51 141.92 (15.12) 139.02 (16.99) -2.90 0.35 -9.13 to 3.33 
Diastolic BP 51 76.71 (10.48) 71.98 (10.32) -4.73 0.01 -8.37 to -1.07 
Weight 49 77.33 (18.30) 76.24 (17.30) -1.08 0.13 -2.48 to 0.31 
BMI 48 30.77 (6.60) 30.40 (6.18) -0.38 0.22 -0.99 to 0.24 
† Figures are mean (st dev). 
 
 Baseline 1 yr follow up p-value † 
Smoking Status 
   Current smoker 
   Ex smoker 
   Non smoker 
 
6 (13%) 
12 (26%) 
29 (62%) 
 
5 (11%) 
13 (28%) 
29 (62%) 
0.56 
Physical Activity 
   Physically impossible 
   Avoids even trivial 
   Light 
   Moderate 
   Heavy 
 
2 (11%) 
1 (5%) 
12 (63%) 
4 (21%) 
0 (0%) 
 
2 (11%) 
2 (11%) 
9 (47%) 
6 (32%) 
0 (0%) 
0.22 
Pulse Left 
   Present 
   Absent 
 
37 (97%) 
1 (3%) 
 
37 (97%) 
1 (3%) 
1.00 
Pulse Right 
   Present 
   Absent 
 
36 (97%) 
1 (3%) 
 
35 (95%) 
2 (5%) 
0.99 
Sense Left 
   Normal 
   Impaired 
 
35 (97%) 
1 (3%) 
 
35 (97%) 
1 (3%) 
1.00 
Sense Right 
   Normal 
   Impaired 
 
34 (100%) 
0 (0%) 
 
33 (97%) 
1 (3%) 
0.99 
Retina Left 
   Normal 
   Mild Background 
   Established 
 
18 (100%) 
0 (0%) 
0 (0%) 
 
18 (100%) 
0 (0%) 
0 (0%) 
--- 
Retina Right 
   Normal 
   Mild Background 
   Established 
 
18 (100%) 
0 (0%) 
0 (0%) 
 
18 (100%) 
0 (0%) 
0 (0%) 
--- 
† McNemars test used so only paired data is analysed. 
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Clinical paired results for males: Appendix 12 
 
 No Pairs Baseline† 1 yr follow up† Mean difference p-value 95% CI for diff 
HbA1c 68 8.09 (1.96) 7.84 (1.55) -0.25 0.32 -0.76 to 0.25 
RBG 36 10.95 (3.21) 9.15 (2.83) -1.80 0.01 -3.24 to -0.40 
Creatinine 64 102.16 (51.26) 109.52 (89.80) 7.36 0.25 -5.18 to 19.89 
Cholesterol 63 5.19 (1.06) 4.47 (0.91) -0.69 <0.001 -1.01 to -0.37 
HDL 43 1.13 (0.27) 1.32 (0.55) 0.19 0.02 0.04 to 0.35 
Systolic BP 79 147.35 (18.61) 140.87 (19.25) -6.48 0.01 -11.61 to -1.35 
Diastolic BP 79 82.06 (10.03) 77.16 (10.99) -4.90 <0.001 -7.39 to -2.41 
Weight 72 90.00 (14.12) 89.93 (14.49) -0.08 0.91 -1.36 to 1.21 
BMI 72 29.57 (4.60) 29.90 (4.79) 0.33 0.20 -0.19 to 0.85 
† Figures are mean (st dev). 
 
 Baseline 1 yr follow up p-value † 
Smoking Status 
   Current smoker 
   Ex smoker 
   Non smoker 
 
15 (22%) 
25 (36%) 
29 (42%) 
 
7 (10%) 
33 (48%) 
29 (42%) 
0.005 
Physical Activity 
   Physically impossible 
   Avoids even trivial 
   Light 
   Moderate 
   Heavy 
 
0 (0%) 
11 (38%) 
13 (45%) 
5 (17%) 
0 (0%) 
 
1 (3%) 
5 (17%) 
10 (35%) 
12 (41%) 
1 (3%) 
0.04 
Pulse Left 
   Present 
   Absent 
 
53 (100%) 
0 (0%) 
 
50 (94%) 
3 (6%) 
0.81 
Pulse Right 
   Present 
   Absent 
 
50 (100%) 
0 (0%) 
 
45 (90%) 
5 (10%) 
0.25 
Sense Left 
   Normal 
   Impaired 
 
43 (84%) 
8 (16%) 
 
45 (88%) 
6 (12%) 
0.69 
Sense Right 
   Normal 
   Impaired 
 
38 (81%) 
9 (19%) 
 
42 (89%) 
5 (11%) 
0.22 
Retina Left 
   Normal 
   Mild Background 
   Established 
 
32 (97%) 
0 (0%) 
1 (3%) 
 
31 (94%) 
1 (3%) 
1 (3%) 
0.99 
Retina Right 
   Normal 
   Mild Background 
   Established 
 
30 (97%) 
0 (0%) 
1 (3%) 
 
29 (94%) 
1 (3%) 
1 (3%) 
0.99 
† McNemars test used so only paired data is analysed. 
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Clinical paired results for <55 yrs: Appendix 13 
 
 No Pairs Baseline† 1 yr follow up† Mean difference p-value 95% CI for diff 
HbA1c 21 8.47 (2.64) 8.10 (1.76) -0.37 0.55 -1.63 to 0.90 
RBG 12 13.53 (3.52) 9.27 (2.89) -4.27 0.006 -7.02 to -1.51 
Creatinine 21 87.48 (56.55) 92.00 (80.70) 4.52 0.56 -11.34 to 20.39 
Cholesterol 22 5.50 (1.06) 4.69 (0.87) -0.81 0.01 -1.42 to -0.20 
HDL 17 1.33 (0.55) 1.47 (0.68) 0.14 0.07 -0.01 to 0.30 
Systolic BP 24 138.92 (14.26) 137.92 (16.35) -1.00 0.74 -7.18 to 5.18 
Diastolic BP 24 83.25 (11.26) 84.79 (11.14) 1.54 0.38 -2.03 to 5.11 
Weight 22 92.51 (21.55) 91.80 (18.14) -0.91 0.51 -3.71 to 1.89 
BMI 22 32.18 (8.05) 32.14 (6.95) -0.05 0.93 -1.14 to 1.04 
† Figures are mean (st dev). 
 
 Baseline 1 yr follow up p-value † 
Smoking Status 
   Current smoker 
   Ex smoker 
   Non smoker 
 
8 (29%) 
3 (11%) 
17 (61%) 
 
3 (11%) 
8 (29%) 
17 (61%) 
0.03 
Physical Activity 
   Physically impossible 
   Avoids even trivial 
   Light 
   Moderate 
   Heavy 
 
1 (10%) 
3 (30%) 
6 (60%) 
0 (0%) 
0 (0%) 
 
1 (10%) 
2 (20%) 
2 (20%) 
4 (40%) 
1 (10%) 
0.09 
Pulse Left 
   Present 
   Absent 
 
23 (100%) 
0 (0%) 
 
22 (96%) 
1 (4%) 
0.99 
Pulse Right 
   Present 
   Absent 
 
21 (100%) 
0 (0%) 
 
19 (91%) 
2 (10%) 
0.82 
Sense Left 
   Normal 
   Impaired 
 
21 (100%) 
0 (0%) 
 
21 (100%) 
0 (0%) 
--- 
Sense Right 
   Normal 
   Impaired 
 
21 (100%) 
0 (0%) 
 
21 (100%) 
0 (0%) 
--- 
Retina Left 
   Normal 
   Mild Background 
   Established 
 
16 (100%) 
0 (0%) 
0 (0%) 
 
16 (100%) 
0 (0%) 
0 (0%) 
--- 
Retina Right 
   Normal 
   Mild Background 
   Established 
 
15 (100%) 
0 (0%) 
0 (0%) 
 
15 (100%) 
0 (0%) 
0 (0%) 
--- 
† McNemars test used so only paired data is analysed. 
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Clinical paired results for 55-64 yrs: Appendix 14 
 
 No Pairs Baseline† 1 yr follow up† Mean difference p-value 95% CI for diff 
HbA1c 18 7.83 (1.51) 7.66 (0.99) -0.17 0.66 -0.99 to 0.65 
RBG 9 10.33 (2.27) 8.77 (2.37) -1.57 0.29 -4.72 to 1.58 
Creatinine 18 111.33 (71.52) 121.50 (140.84) 10.17 0.56 -25.88 to 46.21 
Cholesterol 18 5.01 (0.98) 4.66 (1.09) -0.36 0.31 -1.08 to 0.37 
HDL 10 1.10 (0.20) 1.25 (0.23) 0.16 0.01 0.05 to 0.26 
Systolic BP 22 138.91 (14.32) 136.23 (13.56) -2.68 0.54 -11.62 to 6.26 
Diastolic BP 22 79.72 (8.48) 77.59 (8.21) -2.14 0.42 -7.54 to 3.28 
Weight 20 90.43 (15.95) 92.82 (16.08) 2.19 0.12 -0.61 to 4.96 
BMI 20 30.50 (5.10) 31.60 (5.01) 1.10 0.02 0.19 to 2.01 
† Figures are mean (st dev). 
 
 Baseline 1 yr follow up p-value † 
Smoking Status 
   Current smoker 
   Ex smoker 
   Non smoker 
 
5 (25%) 
9 (45%) 
6 (30%) 
 
4 (20%) 
10 (50%) 
6 (30%) 
0.32 
Physical Activity 
   Physically impossible 
   Avoids even trivial 
   Light 
   Moderate 
   Heavy 
 
0 (0%) 
3 (27%) 
3 (27%) 
5 (46%) 
0 (0%) 
 
0 (0%) 
1 (9%) 
2 (18%) 
8 (73%) 
0 (0%) 
0.26 
Pulse Left 
   Present 
   Absent 
 
17 (100%) 
0 (0%) 
 
17 (100%) 
0 (0%) 
--- 
Pulse Right 
   Present 
   Absent 
 
17 (100%) 
0 (0%) 
 
17 (100%) 
0 (0%) 
--- 
Sense Left 
   Normal 
   Impaired 
 
16 (89%) 
2 (11%) 
 
17 (94%) 
1 (6%) 
1.00 
Sense Right 
   Normal 
   Impaired 
 
13 (87%) 
2 (13%) 
 
14 (93%) 
1 (7%) 
1.00 
Retina Left 
   Normal 
   Mild Background 
   Established 
 
9 (100%) 
0 (0%) 
0 (0%) 
 
8 (89%) 
1 (11%) 
0 (0%) 
0.99 
Retina Right 
   Normal 
   Mild Background 
   Established 
 
9 (100%) 
0 (0%) 
0 (0%) 
 
8 (89%) 
1 (11%) 
0 (0%) 
0.99 
† McNemars test used so only paired data is analysed. 
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Clinical paired results for 65-74 yrs: Appendix 15 
 
 No Pairs Baseline† 1 yr follow up† Mean difference p-value 95% CI for diff 
HbA1c 50 8.25 (1.77) 7.98 (1.70) -0.27 0.29 -0.77 to 0.24 
RBG 22 10.97 (4.08) 8.87 (3.33) -2.10 0.005 -3.49 to -0.70 
Creatinine 45 87.80 (16.91) 86.38 (28.91) -1.42 0.77 -11.34 to 8.50 
Cholesterol 44 4.92 (0.89) 4.36 (0.92) -0.56 <0.001 -0.82 to -0.31 
HDL 32 1.19 (0.21) 1.52 (0.82) 0.34 0.02 0.05 to 0.62 
Systolic BP 55 148.09 (18.13) 143.67 (19.84) -4.41 0.19 -11.01 to 2.18 
Diastolic BP 55 79.51 (10.56) 72.31 (11.06) -7.20 <0.001 -10.48 to -3.92 
Weight 52 82.61 (13.68) 81.67 (14.34) -0.94 0.14 -2.21 to 0.33 
BMI 52 29.46 (4.44) 29.25 (4.41) -0.21 0.46 -0.78 to 0.35 
† Figures are mean (st dev). 
 
 Baseline 1 yr follow up p-value † 
Smoking Status 
   Current smoker 
   Ex smoker 
   Non smoker 
 
6 (13%) 
17 (38%) 
22 (49%) 
 
5 (11%) 
18 (40%) 
22 (49%) 
0.56 
Physical Activity 
   Physically impossible 
   Avoids even trivial 
   Light 
   Moderate 
   Heavy 
 
1 (6%) 
4 (22%) 
11 (61%) 
2 (11%) 
0 (0%) 
 
1 (6%) 
3 (17%) 
10 (56%) 
4 (22%) 
0 (0%) 
0.22 
Pulse Left 
   Present 
   Absent 
 
33 (97%) 
1 (3%) 
 
31 (91%) 
3 (9%) 
0.50 
Pulse Right 
   Present 
   Absent 
 
32 (97%) 
1 (3%) 
 
29 (88%) 
4 (12%) 
0.25 
Sense Left 
   Normal 
   Impaired 
 
28 (88%) 
4 (13%) 
 
30 (94%) 
2 (6%) 
0.63 
Sense Right 
   Normal 
   Impaired 
 
25 (83%) 
5 (17%) 
 
28 (93%) 
2 (7%) 
0.38 
Retina Left 
   Normal 
   Mild Background 
   Established 
 
17 (94%) 
0 (0%) 
1 (6%) 
 
17 (94%) 
0 (0%) 
1 (6%) 
1.00 
Retina Right 
   Normal 
   Mild Background 
   Established 
 
17 (94%) 
0 (0%) 
1 (6%) 
 
17 (94%) 
0 (0%) 
1 (6%) 
1.00 
† McNemars test used so only paired data is analysed. 
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Clinical paired results for >74 yrs: Appendix 16 
 
 No Pairs Baseline† 1 yr follow up† Mean difference p-value 95% CI for diff 
HbA1c 24 7.48 (1.70) 7.31 (1.06) -0.18 0.67 -1.00 to 0.65 
RBG 13 11.84 (4.59) 8.75 (3.66) -3.10 0.05 -6.22 to 0.02 
Creatinine 25 98.80 (27.84) 103.76 (34.06) 4.96 0.32 -5.05 to 14.97 
Cholesterol 18 5.34 (1.42) 4.4 (0.86) -0.90 0.008 -1.54 to -0.26 
HDL 12 1.17 (0.28) 1.26 (0.30) 0.09 0.11 -0.02 to 0.21 
Systolic BP 29 149.79 (18.63) 138.28 (19.77) -11.52 0.02 -21.30 to -1.73 
Diastolic BP 29 78.28 (11.06) 70.62 (6.81) -7.66 0.001 -11.99 to -3.32 
Weight 27 78.87 (17.15) 77.63 (17.86) -1.23 0.17 -3.02 to 0.55 
BMI 26 29.08 (4.82) 28.92 (5.45) -0.15 0.74 -1.08 to 0.77 
† Figures are mean (st dev). 
 
 Baseline 1 yr follow up p-value † 
Smoking Status 
   Current smoker 
   Ex smoker 
   Non smoker 
 
2 (9%) 
8 (35)% 
13 (57%) 
 
0 (0%) 
10 (44%) 
13 (57%) 
0.12 
Physical Activity 
   Physically impossible 
   Avoids even trivial 
   Light 
   Moderate 
   Heavy 
 
0 (0%) 
2 (22%) 
5 (56%) 
2 (22%) 
0 (0%) 
 
1 (11%) 
1 (11%) 
5 (56%) 
2 (22%) 
0 (0%) 
0.25 
Pulse Left 
   Present 
   Absent 
 
17 (100%) 
0 (0%) 
 
17 (100%) 
0 (0%) 
--- 
Pulse Right 
   Present 
   Absent 
 
16 (100%) 
0 (0%) 
 
15 (94%) 
1 (6%) 
0.99 
Sense Left 
   Normal 
   Impaired 
 
13 (81%) 
3 (19%) 
 
12 (75%) 
4 (25%) 
0.99 
Sense Right 
   Normal 
   Impaired 
 
13 (87%) 
2 (13%) 
 
12 (80%) 
3 (20%) 
1.00 
Retina Left 
   Normal 
   Mild Background 
   Established 
 
8 (100%) 
0 (0%) 
0 (0%) 
 
8 (100%) 
0 (0%) 
0 (0%) 
--- 
Retina Right 
   Normal 
   Mild Background 
   Established 
 
8 (100%) 
0 (0%) 
0 (0%) 
 
8 (100%) 
0 (0%) 
0 (0%) 
--- 
† McNemars test used so only paired data is analysed. 
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Clinical paired results for depcats 1&2: Appendix 17 
 
 No Pairs Baseline† 1 yr follow up† Mean difference p-value 95% CI for diff 
HbA1c 23 7.39 (1.47) 7.22 (1.10) -0.17 0.61 -0.84 to 0.51 
RBG 13 11.48 (3.73) 7.19 (3.39) -4.27 0.003 -6.82 to -1.71 
Creatinine 20 97.95 (18.63) 91.20 (26.58) -6.75 0.08 -14.27 to 0.77 
Cholesterol 19 5.41 (1.35) 4.13 (0.82) -1.26 0.001 -1.99 to -0.57 
HDL 16 1.26 (0.30) 1.41 (0.28) 0.18 0.003 0.07 to 0.26 
Systolic BP 29 148.21 (16.92) 138.07 (20.42) -10.13 0.04 -19.57 to -0.71 
Diastolic BP 29 79.24 (11.18) 72.24 (11.15) -7.00 <0.001 -10.50 to -3.50 
Weight 25 78.52 (15.39) 77.74 (14.06) -0.78 0.42 -2.73 to 1.17 
BMI 24 27.33 (3.87) 27.63 (3.55) -0.21 0.61 -1.03 to 0.62 
† Figures are mean (st dev). 
 
 Baseline 1 yr follow up p-value † 
Smoking Status 
   Current smoker 
   Ex smoker 
   Non smoker 
 
3 (14%) 
8 (36%) 
11 (50%) 
 
3 (14%) 
8 (36%) 
11 (50%) 
--- 
Physical Activity 
   Physically impossible 
   Avoids even trivial 
   Light 
   Moderate 
   Heavy 
 
1 (9%) 
2 (18%) 
7 (64%) 
1 (9%) 
0 (0%) 
 
2 (18%) 
0 (0%) 
5 (46%) 
4 (36%) 
0 (0%) 
0.12 
Pulse Left 
   Present 
   Absent 
 
18 (100%) 
0 (0%) 
 
18 (100%) 
0 (0%) 
--- 
Pulse Right 
   Present 
   Absent 
 
17 (100%) 
0 (0%) 
 
17 (100%) 
0 (0%) 
--- 
Sense Left 
   Normal 
   Impaired 
 
15 (94%) 
1 (6%) 
 
14 (88%) 
2 (13%) 
1.00 
Sense Right 
   Normal 
   Impaired 
 
14 (93%) 
1 (7%) 
 
14 (93%) 
1 (7%) 
--- 
Retina Left 
   Normal 
   Mild Background 
   Established 
 
10 (100%) 
0 (0%) 
0 (0%) 
 
10 (100%) 
0 (0%) 
0 (0%) 
--- 
Retina Right 
   Normal 
   Mild Background 
   Established 
 
9 (100%) 
0 (0%) 
0 (0%) 
 
9 (100%) 
0 (0%) 
0 (0%) 
--- 
† McNemars test used so only paired data is analysed. 
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Clinical paired results for depcats 3, 4 & 5: Appendix 18 
 
 No Pairs Baseline† 1 yr follow up† Mean difference p-value 95% CI for diff 
HbA1c 57 8.03 (1.98) 8.09 (1.58) 0.05 0.83 -0.46 to 0.57 
RBG 27 10.91 (3.37) 8.79 (2.68) -2.12 0.01 -3.73 to -0.51 
Creatinine 57 97.00 (53.27) 102.38 (93.71) 5.39 0.41 -7.60 to 18.37 
Cholesterol 54 5.06 (1.02) 4.76 (0.98) -0.30 0.03 -0.57 to -0.04 
HDL 39 1.23 (0.37) 1.53 (0.82) 0.29 0.02 0.06 to 0.52 
Systolic BP 65 143.77 (17.51) 140.28 (16.33) -3.49 0.20 -8.83 to 1.85 
Diastolic BP 65 80.53 (10.12) 75.84 (11.57) -4.69 0.003 -7.71 to -1.67 
Weight 62 84.95 (16.65) 85.46 (17.15) 0.51 0.42 -0.74 to 1.78 
BMI 62 29.60 (4.79) 29.95 (4.93) 0.35 0.18 -0.02 to 0.87 
† Figures are mean (st dev). 
 
 Baseline 1 yr follow up p-value † 
Smoking Status 
   Current smoker 
   Ex smoker 
   Non smoker 
 
13 (22%) 
14 (24%) 
31 (53%) 
 
8 (14%) 
19 (33%) 
31 (53%) 
0.06 
Physical Activity 
   Physically impossible 
   Avoids even trivial 
   Light 
   Moderate 
   Heavy 
 
0 (0%) 
8 (29%) 
12 (43%) 
8 (29%) 
0 (0%) 
 
0 (0%) 
7 (25%) 
9 (32%) 
12 (43%) 
0 (0%) 
0.12 
Pulse Left 
   Present 
   Absent 
 
48 (100%) 
0 (0%) 
 
46 (96%) 
2 (4%) 
0.84 
Pulse Right 
   Present 
   Absent 
 
49 (100%) 
0 (0%) 
 
46 (94%) 
3 (6%) 
0.59 
Sense Left 
   Normal 
   Impaired 
 
39 (85%) 
7 (15%) 
 
43 (94%) 
3 (7%) 
0.22 
Sense Right 
   Normal 
   Impaired 
 
37 (86%) 
6 (14%) 
 
40 (93%) 
3 (7%) 
0.38 
Retina Left 
   Normal 
   Mild Background 
   Established 
 
28 (100%) 
0 (0%) 
0 (0%) 
 
27 (96%) 
1 (4%) 
0 (0%) 
0.99 
Retina Right 
   Normal 
   Mild Background 
   Established 
 
27 (100%) 
0 (0%) 
0 (0%) 
 
26 (96%) 
1 (4 %) 
0 (0%) 
0.99 
† McNemars test used so only paired data is analysed. 
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Clinical paired results for depcats 6 & 7: Appendix 19 
 
 No Pairs Baseline† 1 yr follow up† Mean difference p-value 95% CI for diff 
HbA1c 33 8.58 (2.00) 7.74 (1.58) -0.84 0.04 -1.65 to -0.03 
RBG 16 12.96 (4.78) 10.52 (3.88) -2.43 0.03 -4.52 to -0.33 
Creatinine 32 86.69 (27.03) 91.88 (36.49) 5.19 0.40 -7.14 to 17.52 
Cholesterol 29 5.10 (0.95) 4.26 (0.76) -0.84 <0.001 -1.26 to -0.43 
HDL 16 1.08 (0.25) 1.19 (0.41) 0.11 0.11 -0.02 to 0.25 
Systolic BP 36 145.44 (17.89) 141.58 (20.35) -3.86 0.31 -11.52 to 3.80 
Diastolic BP 36 79.50 (10.87) 76.17 (9.56) -3.33 0.13 -7.74 to 1.07 
Weight 34 89.40 (17.92) 87.30 (17.89) -2.10 0.04 -4.10 to -0.10 
BMI 34 32.44 (6.79) 32.12 (6.46) -0.32 0.47 -1.21 to 0.57 
† Figures are mean (st dev). 
 
 Baseline 1 yr follow up p-value † 
Smoking Status 
   Current smoker 
   Ex smoker 
   Non smoker 
 
5 (14%) 
15 (42%) 
16 (44%) 
 
1 (3%) 
19 (53%) 
16 (44%) 
0.046 
Physical Activity 
   Physically impossible 
   Avoids even trivial 
   Light 
   Moderate 
   Heavy 
 
1 (11%) 
2 (22%) 
6 (67%) 
0 (0%) 
0 (0%) 
 
1 (11%) 
0 (0%) 
5 (56%) 
2 (22%) 
1 (11%) 
0.07 
Pulse Left 
   Present 
   Absent 
 
24 (96%) 
1 (4%) 
 
23 (92%) 
2 (8%) 
0.99 
Pulse Right 
   Present 
   Absent 
 
20 (95%) 
1 (5%) 
 
17 (81%) 
4 (19%) 
0.25 
Sense Left 
   Normal 
   Impaired 
 
24 (96%) 
1 (4%) 
 
23 (92%) 
2 (8%) 
0.99 
Sense Right 
   Normal 
   Impaired 
 
21 (91%) 
2 (9%) 
 
21 (91%) 
2 (9%) 
--- 
Retina Left 
   Normal 
   Mild Background 
   Established 
 
12 (92%) 
0 (0%) 
1 (8%) 
 
12 (92%) 
0 (0%) 
1 (8%) 
--- 
Retina Right 
   Normal 
   Mild Background 
   Established 
 
12 (92%) 
0 (0%) 
1 (8%) 
 
12 (92%) 
0 (0%) 
1 (8%) 
--- 
† McNemars test used so only paired data is analysed. 
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Importance of ongoing education and advice: Appendix 20 
 
 1 (not important) 2 3 4 5 (very important) p-value 
Diet 0 (0%) 0 (0%) 1 (3%) 8 (21%) 31 (82%) <0.001 
Oral Hypoglycaemic Agents 0 (0%) 0 (0%) 2 (5%) 12 (32%) 24 (63%) <0.001 
Insulin Administration 0 (0%) 0 (0%) 3 (8%) 8 (21%) 27 (71%) <0.001 
Insulin Dose Adjustment 0 (0%) 0 (0%) 3 (8%) 8 (21%) 27 (71%) <0.001 
Hypoglycaemia 0 (0%) 1 (3%) 2 (5%) 8 (21%) 26 (70%) <0.001 
Hyperglycaemia 0 (0%) 1 (3%) 4 (11%) 6 (17%) 25 (69%) <0.001 
Blood Glucose Monitoring 0 (0%) 2 (5%) 7 (18%) 10 (26%) 19 (50%) <0.001 
Urinary Glucose Monitoring 5 (14%) 10 (27%) 9 (24%) 7 (19%) 6 (16%) 0.67 
What to do when sick 0 (0%) 1 (3%) 1 (3%) 11 (29%) 25 (66%) <0.001 
Social Eating 0 (0%) 1 (3%) 9 (24%) 17 (45%) 11 (29%) <0.001 
Alcohol 0 (0%) 0 (0%) 5 (13%) 20 (53%) 13 (34%) <0.001 
Exercise 0 (0%) 0 (0%) 2 (5%) 11 (29%) 25 (66%) <0.001 
Foot care 0 (0%) 0 (0%) 2 (5%) 3 (8%) 33 (87%) <0.001 
Smoking 0 (0%) 0 (0%) 0 (0%) 5 (13%) 33 (87%) <0.001 
Psychological Aspects 0 (0%) 1 (3%) 7 (18%) 11 (29%) 19 (50%) <0.001 
Employment 0 (0%) 2 (5%) 8 (21%) 16 (42%) 12 (32%) <0.001 
Sexual Function 0 (0%) 0 (0%) 8 (22%) 15 (41%) 14 (38%) <0.001 
Contraception/ Pregnancy 0 (0%) 0 (0%) 7 (19%) 10 (27%) 20 (54%) <0.001 
Driving & the DVLA 0 (0%) 0 (0%) 9 (24%) 12 (32%) 16 (43%) <0.001 
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Importance of the annual undertaking of parameters: Appendix 21 
 
 1 (not important) 2 3 4 5 (very important) p-value 
Weight 0 (0%) 0 (0%) 6 (16%) 13 (35%) 18 (49%) <0.001 
BMI 0 (0%) 0 (0%) 4 (11%) 10 (27%) 23 (61%) <0.001 
Height 34 (90%) 0 (0%) 2 (5%) 0 (0%) 1 (3%) <0.001 
Dietary Assessment 0 (0%) 0 (0%) 5 (14%) 12 (32%) 20 (54%) <0.001 
Blood Pressure 0 (0%) 0 (0%) 1 (3%) 7 (19%) 29 (78%) <0.001 
Blood Samples Taken 0 (0%) 0 (0%) 0 (0%) 6 (16%) 31 (84%) <0.001 
Testing Urine for Glucose 6 (17%) 4 (11%) 9 (25%) 7 (19%) 10 (28%) 0.53 
Testing Urine for Ketones 2 (6%) 7 (19%) 8 (22%) 4 (11%) 15 (42%) 0.008 
Testing Urine for Protein 1 (3%) 0 (0%) 3 (8%) 7 (19%) 25 (69%) <0.001 
Testing Visual Acuity 1 (3%) 1 (3%) 0 (0%) 8 (22%) 27 (73%) <0.001 
Retinal Screening 0 (0%) 0 (0%) 1 (3%) 5 (14%) 31 (84%) <0.001 
Testing for Neuropathy 0 (0%) 0 (0%) 3 (8%) 6 (16%) 28 (76%) <0.001 
Inspection of Feet/ Footwear 0 (0%) 1 (3%) 3 (8%) 5 (14%) 26 (76%) <0.001 
Inspection of Injection Sites 0 (0%) 2 (5%) 5 (14%) 7 (19%) 23 (62%) <0.001 
Impotence/ Sexual Function 0 (0%) 2 (5%) 6 (16%) 13 (35%) 16 (43%) <0.001 
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Importance of management issues: Appendix 22 
 
Profession 
 All p-value† PM’s GP’s PN’s Pod’s Dietn’s DN’s p-value‡ 
Optimise HbA1c Levels 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
0 (0%) 
0 (0%) 
8 (22%) 
28 (78%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
2 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
4 (33%) 
8 (67%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (17%) 
10 (83%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
5 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (50%) 
2 (50%) 
0.40 
Optimise Blood pressure 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
0 (0%) 
0 (0%) 
5 (14%) 
32 (86%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
2 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (15%) 
11 (85%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (8%) 
11 (92%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
5 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (50%) 
2 (50%) 
0.30 
Treat Abnormal Lipid 
Profile 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
 
0 (0%) 
0 (0%) 
1 (3%) 
8 (22%) 
28 (76%) 
<0.001  
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
2 (100%) 
 
 
0 (0%) 
0 (0%) 
0 (0%) 
3 (23%) 
10 (77%) 
 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (17%) 
10 (83%) 
 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (20%) 
4 (80%) 
 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
 
0 (0%) 
0 (0%) 
1 (25%) 
2 (50%) 
1 (25%) 
0.27 
Return Appointment 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
0 (0%) 
4 (11%) 
9 (24%) 
24 (65%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
2 (100%) 
 
0 (0%) 
0 (0%) 
3 (23%) 
3 (23%) 
7 (54%) 
 
0 (0%) 
0 (0%) 
1 (8%) 
1 (8%) 
10 (83%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
3 (60%) 
2 (40%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (25%) 
3 (75%) 
0.26 
Discuss Individual 
Targets 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
 
0 (0%) 
1 (3%) 
4 (11%) 
14 (38%) 
18 (49%) 
<0.001  
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
2 (100%) 
 
 
0 (0%) 
1 (8%) 
2 (15%) 
6 (46%) 
4 (31%) 
 
 
0 (0%) 
0 (0%) 
1 (8%) 
2 (17%) 
9 (75%) 
 
 
0 (0%) 
0 (0%) 
0 (0%) 
3 (60%) 
2 (40%) 
 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
 
0 (0%) 
0 (0%) 
1 (25%) 
2 (50%) 
1 (25%) 
0.63 
Sources of Help 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
1 (3%) 
4 (11%) 
20 (54%) 
12 (32%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
 
0 (0%) 
1 (8%) 
3 (23%) 
8 (62%) 
1 (8%) 
 
0 (0%) 
0 (0%) 
1 (8%) 
4 (33%) 
7 (58%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
3 (60%) 
2 (40%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
3 (75%) 
1 (25%) 
0.64 
Diabetes UK 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
1 (3%) 
1 (3%) 
7 (19%) 
19 (51%) 
9 (24%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
 
1 (8%) 
1 (8%) 
2 (15%) 
8 (62%) 
1 (8%) 
 
0 (0%) 
0 (0%) 
3 (25%) 
5 (42%) 
4 (33%) 
 
0 (0%) 
0 (0%) 
1 (20%) 
2 (40%) 
2 (40%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
2 (50%) 
1 (25%) 
0.98 
† Chi-squared test for equal proportions used on proportions of each rating answer 
‡ Chi-squared test for equal proportions used on distributions of proportions for each profession. 
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Importance of referrals to other HCP’s: Appendix 23 
 
Profession 
 All p-value† PM’s GP’s PN’s Pod’s Dietn’s DN’s p-value‡ 
Dietitian 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
1 (3%) 
4 (11%) 
7 (19%) 
25 (68%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
0 (0%) 
1 (8%) 
2 (15%) 
2 (15%) 
8 (62%) 
 
0 (0%) 
0 (0%) 
1 (8%) 
3 (25%) 
8 (67%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (20%) 
4 (80%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
0 (0%) 
3 (75%) 
0.87 
Specialist Diabetic Team 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
2 (5%) 
2 (5%) 
7 (19%) 
8 (22%) 
18 (49%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
1 (8%) 
2 (15%) 
3 (23%) 
3 (23%) 
4 (31%) 
 
1 (8%) 
0 (0%) 
4 (33%) 
1 (8%) 
6 (50%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (40%) 
3 (60%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (25%) 
3 (75%) 
0.76 
Retinal Screening Test 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
0 (0%) 
1 (3%) 
8 (22%) 
28 (76%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
1 (8%) 
3 (23%) 
9 (69%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (17%) 
10 (83%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (20%) 
4 (80%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (25%) 
3 (75%) 
0.82 
Exercise Referral 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
1 (3%) 
6 (16%) 
18 (49%) 
12 (32%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
0 (0%) 
1 (8%) 
4 (31%) 
5 (39%) 
3 (23%) 
 
0 (0%) 
0 (0%) 
1 (8%) 
7 (58%) 
4 (33%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
4 (80%) 
1 (20%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
1 (25%) 
2 (50%) 
0.76 
Nephrologist 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
3 (8%) 
12 (33%) 
7 (19%) 
14 (39%) 
0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
0 (0%) 
3 (23%) 
6 (46%) 
2 (15%) 
2 (15%) 
 
0 (0%) 
0 (0%) 
4 (36%) 
1 (9%) 
6 (55%) 
 
0 (0%) 
0 (0%) 
1 (20%) 
3 (60%) 
1 (20%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
0 (0%) 
3 (75%) 
0.12 
Other 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (22%) 
7 (78%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
3 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (100%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0.96 
† Chi-squared test for equal proportions used on proportions of each rating answer. 
‡ Chi-squared test for equal proportions used on distributions of proportions for each profession. 
 
 
NB other is made up of Podiatrist (67%), Vascular Clinic (11%), Chiropody (11%), 
Psychologist (11%). 
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Importance of recording findings and results: Appendix 24 
 
Profession 
 All p-value† PM’s GP’s PN’s Pod’s Dietn’s DN’s p-value‡ 
Medical Notes 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
1 (3%) 
0 (0%) 
1 (3%) 
5 (14%) 
30 (81%) 
<0.001  
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
2 (15%) 
11 (85%) 
 
1 (8%) 
0 (0%) 
0 (0%) 
0 (0%) 
11 (92%) 
 
0 (0%) 
0 (0%) 
1 (20%) 
1 (20%) 
3 (60%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (25%) 
3 (75%) 
0.58 
Practice Diabetes 
Register 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
 
0 (0%) 
0 (0%) 
5 (14%) 
6 (16%) 
26 (70%) 
<0.001  
 
0 (0%) 
0 (0%) 
1 (50%) 
0 (0%) 
1 (50%) 
 
 
0 (0%) 
0 (0%) 
2 (15%) 
4 (31%) 
7 (54%) 
 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
12 (100%) 
 
 
0 (0%) 
0 (0%) 
1 (20%) 
1 (20%) 
3 (60%) 
 
 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
0 (0%) 
 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (25%) 
3 (75%) 
0.07 
Patient Held Records 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
1 (3%) 
4 (11%) 
14 (39%) 
8 (22%) 
9 (25%) 
0.008  
0 (0%) 
0 (0%) 
0 (0%) 
1 (50%) 
1 (50%) 
 
0 (0%) 
3 (23%) 
6 (46%) 
2 (15%) 
2 (15%) 
 
1 (9%) 
0 (0%) 
5 (46%) 
2 (18%) 
3 (27%) 
 
0 (0%) 
1 (20%) 
1 (20%) 
2 (40%) 
1 (20%) 
 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
1 (25%) 
1 (25%) 
2 (50%) 
0.86 
Other 
   1 (not important) 
   2 
   3 
   4 
   5 (very important) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (17%) 
5 (83%) 
---  
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
3 (100%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
 
0 (0%) 
0 (0%) 
0 (0%) 
0 (0%) 
1 (100%) 
--- 
† Chi-squared test for equal proportions used on proportions of each rating answer. 
‡ Chi-squared test for equal proportions used on distributions of proportions for each profession. 
 
 
NB other is made up of IT database (17%), CDSS (34%), Unspecified (49%). 
